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ABSTRACT OF THESIS

CHARACTERIZING AN IN VITRO MODEL OF SEVERE FOCAL TRAUMATIC
BRAIN INJURY IN HIPPOCAMPAL SLICE CULTURES: THE EFFECTS OF
ETHANOL AND CALPAIN INHIBITION BY MDL-28170
In the United States, 2.8 million people suffer a traumatic brain injury (TBI)
annually. Between 25%-50% of TBI injuries happen under alcohol intoxication. It is not
understood how alcohol impacts patient outcomes via secondary injury pathways.
Secondary injury pathways offer a window for therapeutic interventions, but there has been
little success finding effective medications. Slice cultures offer a way to study secondary
injury mechanisms in a controlled manner. The transection injury can model excitotoxicy
seen following TBI. The current studies examined the effect of alcohol intoxication and
withdrawal at the time of injury, and the effect of a calpain inhibitor (MDL-28170) on cell
death following a transection injury. Intoxication had no effect on cell death compared to
the TBI condition. In the ethanol withdrawal (EWD) study, EWD did not increase cell
death following the TBI except at 72 hours. There was no effect of MDL on cell death. The
severity of the model may have caused a ceiling effect. Additionally, imaging points may
not have been sufficient for proper characterization. Future studies should use a
different injury mechanism and other imaging times should be considered.
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Julia Elaine Jagielo-Miller
(Name of Student)
07/17/2019
Date

CHARACTERIZING AN IN VITRO MODEL OF SEVERE FOCAL TRAUMATIC
BRAIN INJURY IN HIPPOCAMPAL SLICE CULTURES: THE EFFECTS OF
ETHANOL AND CALPAIN INHIBITION BY MDL-28170

By
Julia Elaine Jagielo-Miller

Dr. Mark A. Prendergast
Director of Thesis
Dr. Mark Fillmore
Director of Graduate Studies
07/17/2019
Date

DEDICATION
To B.F. Skinner, 113, and 213

ACKNOWLEDGMENTS
I would like to thank my advisor, Dr. Mark Prendergast, and my committee
members, Dr. Michael Bardo and Dr. Robin Cooper, for their support, insight, and
feedback for this project as well as their enthusiasm and inspiration for future work.
Thanks are also due to my lab mate, Caleb Bailey. He demonstrated true collegiality in
his assistance with data collection, text editing and helpful suggestions. His moral support
and friendship throughout this process are greatly treasured. I would also like to thank our
undergraduate lab assistant, Jessica Gebhardt, for her help with data collection as well as
her unfailing optimism. And no acknowledgement would be complete without saying
thank you to Meagan Coomes. As with everything she does, Meagan’s talent and caring
insured that this process went smoothly.
Finally, I want to thank my family for all of their love and support. In particular,
I want to thank my mom for all of her love, support, friendship and mentorship throughout
the years, but especially during this process. Lastly, I want to thank my nephew, Boogie,
for all his unconditional love, tap dancing, and ability to always make me smile.

iii

TABLE OF CONTENTS

ACKNOWLEDGMENTS ................................................................................................. iii
LIST OF FIGURES ........................................................................................................... vi
CHAPTER 1. INTRODUCTION ...................................................................................... 1
1.1

Traumatic Brain Injury ....................................................................................... 1

1.2

Prevalence and Impact ....................................................................................... 4

1.3
Animal Models of TBI ......................................................................................... 7
1.3.1 Weight Drop Models....................................................................................... 8
1.3.2 Controlled Cortical Impact Model .................................................................. 9
1.3.3 Fluid Percussion Model .................................................................................. 9
1.3.4 Impact Acceleration Model........................................................................... 10
1.3.5 Blast TBI Model ........................................................................................... 11
1.4
In Vitro Models ................................................................................................. 12
1.4.1 Compression Models .................................................................................... 13
1.4.2 Stretch Injury Models ................................................................................... 13
1.4.3 Transection Models ....................................................................................... 14
1.5
Secondary Injury ............................................................................................... 15
1.5.1 Edema ........................................................................................................... 16
1.5.2 Inflammation ................................................................................................. 18
1.5.3 Excitotoxicity ................................................................................................ 23
1.6

Medication Development .................................................................................. 28

1.7

Alcohol Use Disorder ....................................................................................... 29

1.8

Risk Factors for AUD ....................................................................................... 29

1.9

Ethanol Induced Damage ................................................................................. 30

1.10

Alcohol Use Prior to TBI .................................................................................. 33

CHAPTER 2. METHODS ............................................................................................... 40
2.1

Hippocampal Slice Culture ............................................................................... 40

2.2

Experiment I: Ethanol Intoxication Prior to TBI .............................................. 40

2.3

Experiment II: Ethanol Withdrawal Prior to TBI ............................................. 41

2.4

Experiment III: Influence of Calpain Inhibition on TBI Induced Cell Death ... 42

2.5

Staining of Cultures with Propidium Iodide ..................................................... 43
iv

2.6

Statistical Analysis ............................................................................................ 44

CHAPTER 3. RESULTS ................................................................................................. 45
3.1
Experiment I: Ethanol Intoxication Prior to TBI .............................................. 45
3.1.1 Effect of Treatment ....................................................................................... 45
3.1.2 Effect of Sex ................................................................................................. 46
3.2
Experiment II: Ethanol Withdrawal Prior to TBI ............................................. 47
3.2.1 Effect of Treatment ....................................................................................... 47
3.2.2 Effect of Sex ................................................................................................. 49
3.3
Experiment III: Influence of Calpain Inhibition on TBI Induced Cell Death ... 50
3.3.1 Effect of Treatment ....................................................................................... 50
3.3.2 Effect of Sex ................................................................................................. 53
CHAPTER 4. DISCUSSION ........................................................................................... 81
REFERENCES ................................................................................................................. 85
VITA ............................................................................................................................... 109

v

LIST OF FIGURES
Figure 2.1 Transection Model………………………………………....................... 44
Figure 3.1.1: Effects of treatment on propidium iodide (PI) uptake in the CA1 region of
hippocampal slices, 24 hours following treatment………………………………… 54
Figure 3.1.2: Effects of treatment on propidium iodide (PI) uptake in the CA3 region of
hippocampal slices, 24 hours following treatment………………………………… 55
Figure 3.1.3: Effects of treatment on propidium iodide (PI) uptake in the DG region of
hippocampal slices, 24 hours following treatment………………………………… 56
Figure 3.2.1: Effects of treatment on propidium iodide (PI) uptake in the CA1 region of
hippocampal slices, 48 hours following treatment……………………………….... 57
Figure 3.2.2: Effects of treatment on propidium iodide (PI) uptake in the CA3 region of
hippocampal slices, 48 hours following treatment………………………………… 58
Figure 3.2.3: Effects of treatment on propidium iodide (PI) uptake in the DG region of
hippocampal slices, 48 hours following treatment………………………………… 59
Figure 3.3.1: Effects of treatment on propidium iodide (PI) uptake in the CA1 region of
hippocampal slices, 72 hours following treatment………………………………… 60
Figure 3.3.2: Effects of treatment on propidium iodide (PI) uptake in the CA3 region of
hippocampal slices, 48 hours following treatment………………………………… 61
Figure 3.3.3: Effects of treatment on propidium iodide (PI) uptake in the DG region of
hippocampal slices, 72 hours following treatment………………………………… 62
Figure 3.4.1: Effects of treatment on propidium iodide (PI) uptake in the CA1 region of
hippocampal slices, 24 hours following treatment………………………………… 63
Figure 3.4.2: Effects of treatment on propidium iodide (PI) uptake in the CA3 region of
hippocampal slices, 24 hours following treatment………………………………… 64
Figure 3.4.3: Effects of treatment on propidium iodide (PI) uptake in the DG region of
hippocampal slices, 24 hours following treatment………………………………… 65
Figure 3.5.1: Effects of treatment on propidium iodide (PI) uptake in the CA1 region of
hippocampal slices, 48 hours following treatment………………………………… 66
Figure 3.5.2: Effects of treatment on propidium iodide (PI) uptake in the CA3 region of
hippocampal slices, 48 hours following treatment………………………………… 67
Figure 3.5.3: Effects of treatment on propidium iodide (PI) uptake in the CA3 region of
hippocampal slices, 48 hours following treatment………………………………… 68

vi

Figure 3.6.1: Effects of treatment on propidium iodide (PI) uptake in the CA1 region of
hippocampal slices, 72 hours following treatment………………………………… 69
Figure 3.6.2: Effects of treatment on propidium iodide (PI) uptake in the CA3 region of
hippocampal slices, 72 hours following treatment………………………………… 70
Figure 3.6.3: Effects of treatment on propidium iodide (PI) uptake in the DG region of
hippocampal slices, 72 hours following treatment………………………………… 71
Figure 3.7.1: Effects of treatment on propidium iodide (PI) uptake in the CA1 region of
hippocampal slices, 24 hours following treatment………………………………… 72
Figure 3.7.2: Effects of treatment on propidium iodide (PI) uptake in the CA3 region of
hippocampal slices, 24 hours following treatment………………………………… 73
Figure 3.7.3: Effects of treatment on propidium iodide (PI) uptake in the DG region of
hippocampal slices, 24 hours following treatment………………………………… 74
3.8.1: Effects of treatment on propidium iodide (PI) uptake in the CA1 region of
hippocampal slices, 48 hours following treatment………………………………… 75
Figure 3.8.2: Effects of treatment on propidium iodide (PI) uptake in the CA3 region of
hippocampal slices, 48 hours following treatment………………………………… 76
Figure 3.8.3: Effects of treatment on propidium iodide (PI) uptake in the DG region of
hippocampal slices, 48 hours following treatment………………………………… 77
Figure 3.9.1: Effects of treatment on propidium iodide (PI) uptake in the CA1 region of
hippocampal slices, 72 hours following treatment………………………………… 78
Figure 3.9.2: Effects of treatment on propidium iodide (PI) uptake in the CA3 region of
hippocampal slices, 72 hours following treatment………………………………… 79
Figure 3.9.3: Effects of treatment on propidium iodide (PI) uptake in the DG region of
hippocampal slices, 72 hours following treatment………………………………… 80

vii

CHAPTER 1. INTRODUCTION
1.1

Traumatic Brain Injury
Traumatic brain injury (TBI) is an inclusive term for a wide range of pathologies

seen following injury to the brain. One issue with diagnosing TBIs is the lack of a universal
definition. For example, the Center for Disease Control (CDC) very generally defines a
TBI as being “caused by a bump, blow, or jolt to the head or a penetrating head injury that
disrupts the normal function of the brain” (Faul and Coronado, 2015). However, the
revised (version 2.0) US Department of Veterans Affairs and the Department of Defense’s
Clinical Practice Guideline For Management of Concussion-mild Traumatic Brain Injury
defines a TBI as a “traumatically induced structural injury and/or physiological disruption
of brain function as a result of an external force and is indicated by new onset or worsening
of at least one of the following clinical signs immediately following the event: any period
of loss of or a decreased level of consciousness, any loss of memory for events immediately
before or after the injury (posttraumatic amnesia), any alteration in mental state at the time
of injury (e.g., confusion, disorientation, slowed thinking, alteration of conscious/mental
state), neurological deficits (e.g., weakness, loss of balance, change in vision, praxis,
paresis/plegia, sensory loss, aphasia) that may or may not be transient or intracranial
lesion” (VA DoD, 2016). In 2010, part of the International and Interagency Initiative
towards Common Data Elements for Research on Traumatic Brain Injury and
Psychological Health came up with a definition of what constitutes a TBI: “an alteration in
brain function, or other evidence of brain pathology, caused by an external force”
(Hawryluk and Manley, 2015). The lack of consensus in definition may contribute to the
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underdiagnosing and under treatment of TBIs (Menon, Schwab, Wright, and Maas, 2010;
Prince and Bruhns, 2017), and makes comparison of TBI data sets difficult (Faul and
Coronado, 2015).
Despite the heterogeneity of TBIs, they are all believed to trigger various pathways
that lead to alterations in inflammation, metabolic, axonal, and neuronal function (Shultz
et al., 2017). The two most common forces that result in TBIs are a direct impact to the
head or the head quickly being accelerated/rotated (Gennarelli, 1994), although
penetrative, compressive and blast forces can result in TBIs as well (Shultz et al, 2017).
Given the wide range of forces, it is unsurprising that there are a wide range of pathologies
that can be seen following a TBI.
The most common ways of classifying pathologies are by focal vs. diffuse injury
and by primary vs. secondary injury. Focal injuries include skull fracture, contusions,
hematomas, and hemorrhages, whereas edema, diffuse axonal injury (DAI), oxidative
stress, and excitotoxicity are categorized as diffuse pathologies (McKee and Daneshvar,
2015). Primary injuries are considered to be “direct” and are incurred as a result of the
injuring force. They are then believed to cause secondary injury (Hawryluk and Manley,
2015; McKee and Daneshvar, 2015).

Secondary injuries include mitochondrial

dysfunction, excitotoxicity, increased production of free radicals (Hawryluk and Manley,
2015), secondary hemorrhage, hypotension, hypoperfusion, hypoxia, ischemia,
neuroinflammation, and edema (McKee and Daneshvar, 2015).

It is important to

acknowledge that these pathologies do not happen in isolation from one another, do not
occur in every incident of a TBI, nor do they occur with identical frequencies.

2

TBIs can also be categorized based on severity from mild to moderate to severe by
assessing symptoms and physiological signs post injury (Barlow, 2013). The Glasgow
Coma Scale (GCS) assesses patient function post TBI and helps classify the severity of the
injury (Barlow, 2013). The GCS quantifies patients’ ability to open their eyes, their motor
and verbal responses on a scale from 3-15 with 3 indicating no response and 15 indicating
no noticeable deficits (Barlow, 2013). GCS scores of 13-15, 9-12, and 3-8 indicate a mild,
moderate, and severe TBI, respectively. The GCS is a commonly used assessment as it
can be conducted quickly and easily (Barlow, 2013). However, there are concerns with
using the GCS as it shows poor inter-rater reliability, especially when given by
inexperienced administrators (Barlow, 2013; Teasdale et al., 2014; Zuercher,
Ummenhofer, Baltussen, and Walder, 2009). Andriessen et al. (2011) suggest that GCS
scores taken at the injury site may contradict emergency department scores up to 15% of
the time. This is especially concerning since GCS scores play a major role in determining
the best facility for patient admission (Sasser et al., 2012). The GCS is time sensitive, so
any delay in assessment can inappropriately impact the scores (Barlow, 2013). GCS scores
can also be influenced by patient inebriation and facial swelling at the time of the
assessment (Faul and Coronado, 2015). In fact, GCS scores can be influenced by a wide
range of patient factors and conditions including age, presence of other psychological
disorders, and facial or nerve damage, as well as factors that may be instigated by the
treatment facility such as sedation, intubation, and administration of blockers of
neuromuscular transmission (Middleton, 2012; Teasdale et al., 2014; Zuercher et al., 2009).
The GCS does not have an animal equivalent for use in research, which hinders
translatability of TBI research to clinical settings (Faul and Coronado, 2015). Other scales
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have been utilized but have their own limitations. One such assessment is based on the
length of time a patient experiences a loss of consciousness (LOC) post injury, however,
this has been shown to be an unreliable indicator of a patient even having a TBI (Faul and
Coronado, 2015). Another measure assesses the length of time a patient experiences posttrauma amnesia. The problem with this measure is that not all TBI patients experience
amnesia following injury (Faul and Coronado), however, when patients do experience posttrauma amnesia, this assessment is indicative of the severity of impairment (Khan,
Baguely, and Cameron, 2003). Not surprisingly, individuals that have just received a TBI
may struggle with accurately reporting their symptoms, so measures of TBIs that rely on
self-report pose validity concerns (Faul and Coronado, 2015).

1.2

Prevalence and Impact
It is estimated that 2.8 million people in the United States (U.S.) sustain a traumatic

brain injury (TBI) every year, and 50,000 of these individuals die annually (Taylor, Bell,
Breiding, and Xu, 2017). These numbers, however, are believed to underestimate the
prevalence of both TBIs and TBI-related deaths. Prevalence of TBIs is reported as the
number of cases per 100,000 of the population using emergency department visits, and
varies by age. TBIs are most prevalent in the elderly (age 75+) with 1701.7 cases per
100,000, followed by children aged 0-4 years old with 1541.1 cases per 100,000 (Taylor et
al., 2017). TBI patients in the 75+ age group also experience the highest rates of
hospitalization and death due to TBIs, followed in these categories by patients in the 6574 age range (Taylor et al., 2017). While the elderly have the highest rate of TBIs based on
the population, patients aged 15-24 make up 17.9% of TBI-related emergency department
visits, which is more than any other age group (Taylor et al., 2017).
4

Rodriguez, Mallonee, Archer, and Gofton (2006) conducted a study examining
deaths certificates in Oklahoma in 2002 for individuals that had multiple causes of death
listed. They found that found that 212 of the 952 deaths that included TBIs were classified
as false negatives (i.e. a TBI was a cause of death but was not reported as such), making
death certificate surveillance only 78% sensitive for TBIs (Rodriguez et al., 2006). The
majority of death certificates that fell into the false negative category (69%) had the cause
of death listed as “multiple trauma,” mainly as the result of automobile accidents (86%).
Many of the death certificates were incomplete or completed incorrectly, accounting for
91% of the false negatives (Rodriguez et al., 2006). While this study only encompassed
Oklahoma, it is plausible that other states may suffer similar inadequacies in reporting. A
small scale study in Finland found that 74.2% patients that were admitted to a rehabilitation
center for spinal cord injury (SCI) also presented symptoms of TBIs which went
undiagnosed (Tolonen, Turkka, Salonen, Ahomiemi, and Alarant, 2007). Unsurprisingly,
a SCI patient also suffering from an undiagnosed (and therefore untreated) TBI can
encounter additional concerns and have worse patient outcomes than if the TBI is
diagnosed and treated (Tolonen et al., 2007). Schootman and Fuortes (2000) suggest that
underreporting may occur for other reasons as well. Since the annual number of TBIs is
taken from emergency departments (ED), it cannot take into account TBIs that were treated
in outpatient facilities, which may result in as many as 89,000 unreported TBIs per year.
TBIs, particularly mild TBIs (mTBI), may go undiagnosed and untreated with estimates
suggesting that 11-75% of TBIs are not diagnosed (reviewed in Faul and Coronado, 2015).
Possible explanations for this discrepancy include a lack of proper education regarding
TBIs as well inaccessibility of health care resources (Faul and Coronado, 2015).

5

Traumatic brain injuries are responsible for an economic burden of $76 billion in
the U.S every year (CDC, 2019; Finkelstein, Corso, and Miller, 2006). The cost of
productivity loss from TBIs is higher than productivity loss associated with any other injury
(Faul and Coronado, 2015). In addition to the cost to society, the economic burden of TBIs
to patients and their families is also extensive. It is difficult to truly measure lifetime costs
following a TBI, however, one study found that from the time of TBI to six years post
injury, TBI patients had significantly higher health care costs than their matched controls
(Leibson et al., 2012). Unsurprisingly, more severe TBIs were associated with higher
medical costs than more mild TBIs (Leibson et al., 2012). Lifetime costs depends on the
severity of the injury but the estimated lifetime cost of caring for a person with a TBI is
between $600,000 and $1,875,000 (“Brain Injury Costs”, 2017). Compounding this
financial burden is that TBI patients have very high rates of unemployment, with studies
estimating the rate of unemployment for up to two years post injury is between 42%
(Doctor et al., 2005) and 60% (Cuthbert et al., 2015). This is especially concerning given
that employment has been associated with better patient outcomes and improved quality of
life (reviewed in Wehman, Targett, West, and Kregel, 2005).
While individuals can receive a TBIs through a number of different means, falling,
being struck by or striking against an object, and motor vehicle accidents are the three most
common causes of TBI-related emergency room visits, hospitalizations and deaths (Taylor
et al., 2017). TBIs induced by falls make up the majority of TBIs for the youngest age
group (0-4 years old) and the oldest age group (65+ years old), accounting for 72.8% and
81.8% of TBIs in the age groups, respectively (CDC, 2016). However, in both the age
groups of 15-24 and 25-44 year olds, the percentage of TBIs induced by automobile
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accidents, assaults and falls are similar, with each making up ~20% of the TBIs in the age
group (CDC, 2016). Using emergency department visit information, men are more likely
than women to experience a TBI, although the ratio varies between age groups (Faul, Xu,
Ward, and Coronado, 2010). There have been a few studies looking at distribution of TBIs
across race and these data also show that black individuals had the highest reported rate of
TBI (Faul et al., 2010), but the racial categories used were far from inclusive. It has also
been shown that emergency room care given to racial minorities following mTBIs can vary
from care given to white patients including increased time to see a health care provider,
departure from the emergency room department prior to being seen, increased likelihood
of being seen by a resident instead of a staff physician or emergency medicine tech, while
being subjected to over testing compared to white patients (Bazarian, Pope, McClung,
Cheng, and Flesher, 2003). These discrepancies in care may play a role in the why African
Americans have been reported to experience worse psychological outcome compared with
white patients (Jorge, Robinson, Starkstein, and Arndt, 1994).

1.3

Animal Models of TBI
There are a variety of animal models of TBI that can be used in numerous species

as well as in cell culture methods. Rodent models of TBI are the most commonly used due
to the reduced expense and increased convenience over larger animals (Johnson et al.,
2015; Xiong, Mahmood, and Chopp 2013). This has allowed the outcome measures of the
rodent models to become more standardized than those for other animals (Xiong et al.,
2013). Despite this, a major concern of using rodent models is that the physiology and size
of the species is further removed from humans than is the case for larger animals (Xiong
et al., 2013) which may hinder translatability of these models to clinical populations.
7

Additionally, there are concerns that attempting to scale the injury to a brain significantly
smaller than a human’s may also hinder translatability (Johnson et al., 2015).
Animal models of TBI can be categorized based on the type of injury they induce:
focal, diffuse, mixed, or combined (Morales et al., 2005). Animal models that induce a
focal injury include models such as the weight-drop models, controlled cortical impact
(CCI), and midline fluid percussion injury (FPI) (Morales et al., 2005).
1.3.1

Weight Drop Models
The weight-drop induced TBI is very commonly used and is believed to be the

original experimental model (Morales et al., 2005). It can be varied to produce a range of
severities based on the weight dropped and the height from which it is dropped (Xiong et
al., 2013). Feeney, Boyeson, Linn, Murray, and Gail (1981) adapted a spinal cord injury
device to induce a TBI, in brief, by dropping a weight down a thin tube onto a footplate
placed on the exposed of dura of rats (Feeney et al., 1981). Unfortunately, although the
Freeney weight-drop model is capable of producing consistent injuries, it can have a high
rate of mortality (Xiong et al., 2013). A variant of this model was later developed in which
the weight was dropped onto a closed headed rat (Shapira et al., 1988). Due to the increased
protection this model offers the skull, it is sometimes referred to as a model of mTBI
(Shultz et al., 2017). This weight-drop model (commonly referred to as the Shohami
model) is easy to perform, but may not produce consistent injuries across animals or
laboratories (Xiong et al., 2013). Although the Shohami weight-drop model is usually
classified as a focal injury model (Morales et al., 2005; Xiong et al., 2013), it is sometimes
included as model of mixed injury (Shultz et al., 2017). Weight-drop models are easy to
perform and are clinically relevant, but there are concerns about the weight rebounding and
8

inducing a second injury as well as concerns with the accuracy of the injury induced
(Morales et al., 2005).
1.3.2

Controlled Cortical Impact Model
The CCI model relies on a small pneumatic impactor to deliver a calculated blow to

the exposed dura that deforms the brain tissue (Dixon, Clifton, Lighthall, Yaghami, and
Hayes, 1991). The CCI model can be used to give a range of TBI severities (mild to severe)
and is considered to be give a more accurate and consistent injury than weight drop and
fluid percussion models (Romine, Gao, and Chen, 2014; Xiong et al., 2013). The impactor
can be placed over the midline or the lateral cortex to model injuries sustained at different
sites (Romine et al., 2014). While the CCI model is believed to model human TBIs well,
it can also cause pathologies that are not typically seen in the clinical population (Romine
et al., 2014). There is some concern that the CCI model can lead to high rates of mortality
(Romine et al., 2014), but others report the CCI model has a low rate of mortality (Xiong
et al., 2013). Additionally, CCI models requires a craniotomy, opening of the skull, which
decreases the translatability to the clinical population (Xiong et al., 2013).
1.3.3

Fluid Percussion Model
Early FPI experiments were primarily performed on cats, rabbits, and nonhuman

primates but the FPI model was adapted for the rat in the 1980s (Dixon et al., 1987;
McIntosh et al., 1989). A few labs worked to thoroughly characterize the FPI model for
rats at a range of severities (Dixon et al., 1987; McIntosh, Noble, Andrews and Faden,
1987). FPI, in brief, induces injury when a weight on a pendulum is dropped from a
predetermined height and strikes a piston on a Plexiglas cylinder filled with 37º C saline.
9

The other end of the cylinder is a transducer with a Leur-Loc that can be fastened to a LeurLoc implanted over a rat’s exposed dura. When the weight hits the piston, it creates a pulse
that briefly increases intracranial pressure that deforms the brain tissue (Dixon et al., 1987;
McIntosh et al., 1989). The severity of the TBI can be altered by adjusting the height from
which the weighted pendulum is dropped (Dixon et al., 1987). The craniotomy can be
done either on the midline or laterally, which is considered a mixed injury model (Morales
et al., 2005), allowing it to translate to a wider variety of clinical cases (McIntosh et al.,
1987; McIntosh et al., 1989).
1.3.4

Impact Acceleration Model
Some animal models of TBI induce a more diffuse pattern of injury, thus

broadening the scope of injuries that can be investigated. One of the most commonly used
diffuse injury models is the impact acceleration model. In brief, a steel plate is affixed to
the rat skull and the anesthetized rat is then placed on a foam pad with the steel plate
directly under a thin Plexiglas tube. A known weight is dropped down the tube from a
known distance and strikes the steel plate on the rat’s skull. The steel plate allows the force
to disperse more widely across the skull, which works to prevent skull fracture as well as
produce a more diffuse pattern of injury. Once the weight has struck the steel plate, the
pad is moved to prevent a secondary impact of the weight (Marmarou et al., 1994), which
is a drawback of other weight-drop models. Another advantage of the foam pad in the
Marmarou model is that it allows for a rotational injury, which is believed to be critical to
produce a loss of consciousness (Schultz, 2017). This is especially clinically relevant as
some definitions of TBI require a loss or alteration of consciousness (VA DoD, 2016) and
diagnoses of mTBI cannot be made without LOC or altered consciousness (National Center
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for Injury Prevention and Control, 2003). However, due to the nature of this model, the
injuries produced are not highly consistent between animals and there is a high mortality
rate for the animals due to respiratory depression if they do not receive ventilation post
injury (Marmarou et al., 1994; Xiong et al., 2013). A newer variation of this model utilizes
an air-driven impactor, guided with the use of a laser, to hit a steel plate affixed to the rat’s
skull while the rat’s head is placed over a gel base which slows the head down post impact
while allowing the head to rotate (Cernak et al., 2004).
1.3.5

Blast TBI Model
Due to the high rates of TBIs in military populations, a model of blast-induced TBI

was created (Faul and Coronado, 2015; Xiong et al., 2013). There are various animal
models used to mimic blast TBIs in use (e.g. Cernak et al., 2011; Cheng et al, 2010; Reneer
et al., 2011; Rubovitvh et al., 2011), causing blast TBI models to suffer from a lack of
standardization (Xiong et al., 2013). Briefly, this model uses a variety of mechanisms
(from explosives to shock tubes) to model injuries received from explosions. Explosions
release a large amount of energy, causing an increase in temperature, followed by a drop
in pressure resulting in a shockwave (Ning and Zhou, 2015). The initial injury from the
blast can be followed by injuries from flying debris, burns, the acceleration of the body,
etc. (Ning and Zhou, 2015). Real world blast incidents can induce multiple TBIs including
acceleration injuries, penetrating injuries and injuries from being struck (Johnson et al.,
2015). Unfortunately, due to the nature of real world blast injuries, there is not a clinical
population that has experienced a pure blast injury, which hinders the development of
animal models of blast TBIs (Johnson et al., 2015).
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Combined models of TBI include the original TBI injury using one of the
previously described models, followed by a secondary injury such as ischemia or
temporary hypoxia that serves to exacerbate the initial insult (Morales et al., 2005). These
models may be especially beneficial as hypotensive and hypoxic episodes are common
following TBIs in clinical populations (Marshall et al., 1975).

1.4

In Vitro Models
In addition to the in vivo models, there is also a variety of in vitro models of TBIs.

In vitro models can utilize either dissociated cell cultures or slice cultures. Cell cultures
provide a highly controlled and repeatable way to study various diseases and disorders
(Morrison, Elkin, Dollé, and Yarmush, 2011). Additionally, use of culturing methods can
help to lower the number and distress of laboratory animals used (Humpel, 2015).
Dissociated cell cultures allow for the study of a specific type of cell, such as neurons or
astrocytes; however, while they can provide information about cell survival, morphology
and responses to various toxins, chemicals and pharmaceuticals, etc. they also suffer from
a lack of translatability because they exist in isolation outside of their natural environment
(Humpel, 2015). This isolation can be beneficial for studying effects of a manipulation on
a specific type of cells without systematic confounds that would exist in whole animals
(Morrison et al., 2011). While dissociated cell cultures can be beneficial for isolated
populations of cells, organotypic slice cultures have the advantage that the majority of the
cellular structure is preserved. Because the structure is maintained, information about
cellular and molecular workings of the different population of cells naturally interacting in
the brain can be gathered (Humpel, 2015). Organotypic slice cultures can be a middle
ground between dissociated cell cultures and in vivo studies.
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1.4.1

Compression Models
Some in vitro models mimic the in vivo models, such as the compression models

(Morrison et al., 2011). The compression model of TBI mirrors the weight drop model of
TBI in live animals onto brain tissue cultures (Morrison et al., 2011). In the compression
model, a stylus is positioned over the tissue and dropped onto the impact site and is
controlled with electromagnets (Sieg, Wahle, and Pape, 1999). Similar to weight drop
models, the severity of the injury impacted by the compression models can alter the severity
of the injury by varying the height of the drop, the weight dropped, the duration of the
injury as well as the depth of the injury (Morrison et al., 2011). Unfortunately, the force
of injury and the deformation of the brain tissue are hard to measure, making these models
hard to standardize (Morrison et al., 2011).
1.4.2

Stretch Injury Models
Stretch injury models are another common method of inducing TBI-like injuries in

vitro. These models were designed to mirror the tissue deformation seen in TBIs (Morrison
et al., 2011). One mechanism of inducing this injury on the cells/tissue is with the use of
compressed air. Cells are placed on a flexible membrane and compressed gas is used to
distort the membrane, stretching (and therefore damaging) the cells for a set duration (Ellis,
McKinney, Willoughby, Liang, and Povlishock, 1995). In a variation on the stretch model,
slices are again placed on a flexible membrane, but instead of using compressed gas, the
flexible membrane is stretched over an indenter (Morrison, Cater, Benham, and Sundstrom,
2006). A drawback to this model is that the injury is not uniform and therefore not well
characterized (Morrison et al., 2011).
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1.4.3

Transection Models
Another method of inducing traumatic injury is with transection models (Morrison

et al., 2011). The transection models are beneficial for modeling primary axotomy which
results in cell death. These can work on single cells or multiple cell cultures (Morrison et
al., 2011). There are variations of the transection models including a device that rotates
needle(s) to create concentric circles of damage in a mixed culture of neuronal and glial
cell cultures (Mukhin, Ivanova, Knoblach, and Faden, 1997). This particular model results
in primarily neuronal cell death while glia remain relatively unharmed (Mukhin et al.,
1997). Mukhin et al. (1997) also found glutamate antagonists were neuroprotective in this
injury model, indicating that this model may be especially beneficial for studying
glutamate-dependent secondary injury. A year later, the same group devised a variant on
this model, utilizing an injury device (mechanical punch device) that was composed of 28
parallel blades that are pressed into either glial or neuronal/glial cell cultures (Mukhin,
Ivanova, Allen, and Faden, 1998). Glial cultures showed cell death isolated to points of
injury; however, this injury mechanism showed a spread of cell death from the points of
injury in neuronal/glial cell cultures and, as in the previous model, NMDA antagonists
were neuroprotective (Mukhin et al., 1998).
Transection models can also be used with organotypic hippocampal slice cultures
(OHSC).

Organotypic slice cultures may provide more translatable models than

dissociated cell cultures since the culturing of tissues allows for the preservation of the
structural and organizational integrity of the tissue (Humpel, 2015). One transection model
in OHSCs induces injury by slicing through the cornu ammonis (CA) 2 region of the
hippocampus with a scalpel to transection the Schaffer collateral fibers (Laskowski,
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Schmidt, Dinkel, Martinez-Sánchez, and Reymann, 2005). Schaffer collateral fibers run
from the CA3 to the CA1 region of the hippocampus and are believed to play a role in
plasticity and memory formation (Sevilla, Cabezas, Prada, Sánchez‐Jiménez, and Buño,
2002; Teixeira et al., 2018). Our lab has also looked at the effect of different transections
of OHSCs. Mulholland and Prendergast (2003) measured the neurotoxic effects of
transecting different areas of OHSCs, specifically the mossy fibers, Schaffer collateral
fibers, and alveus fibers. This model of TBI may be more applicable for specific types of
TBIs (i.e. penetrating injuries/bullet wounds) or for modeling specific features of TBIs,
such as axotomies and excitotoxicity.
Although none of these in vitro models can accurately encompass all aspects of a
TBI and may not be as translatable to clinical settings as in vivo models, models of TBI
can provide valuable information about secondary injury pathways.

1.5

Secondary Injury
Primary injuries in TBI include contusion, hematoma, shearing, and skull fracture

(Coles, 2004; Park, Bell, and Baker, 2008; Xiong, Zhang, Mahmood, and Chopp, 2015)
that occur as the result of the brain being displaced in the skull at the time of trauma (Prins,
Greco, Alexander, and Giza, 2013). Primary injury is typically focal in nature (with some
exceptions for rotational injuries) whereas secondary injury mechanisms exacerbate and
expand upon the original injury (Borgens and Snyder, 2012).
Generally, secondary injury is defined as a “restricted set of intracellular
biochemical processes that occur over time after cells are compromised” and includes
various injuries such as edema, ischemia and hemorrhage (Borgens and Snyder, 2012).
Brain tissue, as well as spinal cord tissue, is particularly susceptible to hemorrhage,
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ischemia, and edema as the tissue is surrounded by inflexible bone. When an injury does
occur, the pressure on the tissue increases, causing further damage following the original
insult (Borgens and Snyder, 2012). A TBI can sever or rupture blood vessels and this
restriction in/lack of blood flow (ischemia) deprives the tissue of oxygen and glucose which
can lead to delayed cell death (Borgens and Snyder, 2012).
1.5.1

Edema
Edema, an increase in water content, can exacerbate ischemia if the swelling

restricts blood flow, but more importantly, edema can lead to compression of the brainstem,
which can cause death (Borgens and Snyder, 2012; Ho, Rojas, and Eisenberg, 2012; Xiong
et al., 2015). Edema can be caused by various mechanisms but is usually classified as
either cytotoxic, vasogenic, interstitial, or combined (Ho et al., 2012). Typically, edema
following TBIs is listed under the combined category and can have multiple contributing
factors (Ho et al., 2012).
Cytotoxic edema typically results from ischemia or excitotoxicity. This results in
increased fluid in neurons, glia, axons and myelin, with gray matter being impacted first.
If there is repeated insult, the blood brain barrier (BBB) may become compromised (Ho et
al., 2012). Vasogenic edema occurs when the endothelial junctions in the BBB become
compromised, which can happen from the BBB being physically disturbed. This type of
edema can be corrected in the early stages if the BBB is reconstructed, however, if
vasogenic edema becomes too advanced or occurs repeatedly, the resulting damage is not
correctable and may cause or exacerbate ischemia or lead to cytotoxic edema (Ho et al.,
2012). Interstitial edema varies from the previous types as the increased pressure is in the
ventricles. This increase in pressure causes the lining of the ventricles to rupture which in
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turn allows the cerebral spinal fluid (CSF) to move to extracellular space. This type of
edema is most commonly caused by conditions such as tumors, meningitis, hydrocephalus,
and subarachnoid hemorrhage (Ho et al., 2012).

Interstitial edema is also open to

intervention depending on the cause (e.g. removal of mass, insertion of catheter, etc.) (Ho
et al., 2012).
Edema is one type of secondary injury that has been invested for therapeutic
intervention. One of the factors that mediates vasogenic edema is bradykinin, (Borgens
and Snyder, 2012). Bradykinin is an important peptide that plays a role in regulating blood
pressure and inflammatory response by increasing vascular permeability (Golias,
Charalabopoulos, Stagikas, Charalabopoulos, and Batistatou, 2007). Because of this, a
bradykinin antagonist (Bradycor) went to clinical trials. Bradycor failed the clinical trial,
but the trial was cut short due to an animal study that came out following the start of the
clinical trial which aroused concerns about the safety of Bradycor (Narayan et al., 2002).
In addition to vasogenic factors (such as bradykinin), there are also cytotoxic factors that
contribute to edema and may provide other therapeutic targets. These cytotoxic factors
include glutamate, arachidonic acid metabolites, and free radicals, etc. (Borgens and
Snyder, 2012). While breakdown of the BBB can result in edema, it also allows for
infiltration of immune cells from the periphery into the brain which can cause
neuroinflammation, another major type of secondary injury (Schimmel, Acosta, and
Lozano, 2017).
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1.5.2

Inflammation
The inflammatory process is initiated shortly after trauma occurs. There is some

debate over the usefulness of inflammation following TBI. In general, inflammation is
complex set of interactions that are triggered by the introduction of trauma, infectious
agents, and toxins, etc. (Nathan, 2002). TBIs (as well as ischemia) are categorized as sterile
triggers of inflammation (as opposed to infectious triggers) (Rock, Latz, Ontiveros, and
Kono, 2009). Neuroinflammation is complex as it can be both beneficial as well as
damaging.

Neuroinflammation is associated with the release of growth factors and

proteolytic enzymes that aid in regeneration (Borgens and Snyder, 2012). Macrophages
help clear debris (dead and damaged cells and myelin) that otherwise prevents regeneration
(Borgens and Snyder, 2012). On the other hand, neuroinflammation can be detrimental as
an overabundance of inflammatory cells can exacerbate edema, lead to more apoptosis
which is mediated through cytokines and free radicals (Borgens and Snyder, 2012).
The inflammatory response following trauma includes a variety of cells including
macrophages, neutrophils, astrocytes and microglia, and T cells (Corps, Roth, and
McGavern, 2015). The TBI causes the release of alarmins, endogenous damage-associated
molecular pattern molecules (DAMPs), which are interpreted as “danger” or “warning”
signals (Bianchi, 2007; Corps et al., 2015). These alarmins, which include HMGB1, ATP,
DNA, and interleukins, as well as many others, lead to the triggering of the inflammatory
response (Corps et al., 2015). All cells contain ATP, but when it is released, it is believed
to play a role in regulating a host of functions from cardiac functioning to vasodilation to
neurotransmission (Bours, Swennen, Virgilio, Cronstein, and Dagnelie, 2006; Yegutkin,
2008).

In particular, ATP release following trauma triggers immunological and
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inflammatory responses through purinergic signaling (Bours, et al., 2006; Corps et al.,
2015). ATP can get into the extracellular space either through controlled release from
living cells (Junger, 2011) or can rush from cells that have been injured (Virgilio, 2005).
Following trauma, ATP is believed to be released from cells surrounding the trauma area
as well as from the cells damaged in the initial injury (Virgilio, 2005). In one study of
spinal cord injury (SCI), the cells in the perilesion area released even more ATP than cells
that were in the original area of trauma (Wang et al., 2004). Once it is released from
damaged cells, ATP activates purinergic 2 (P2) receptors. However, as ATP is metabolized
from ATP to ADP to AMP to adenosine, this process of hydrolysis ends the activation of
the P2 receptors, and enables receptor desensitization allowing for quick and frequent
signaling (Junger, 2011; Yegutkin, 2008). During this process, the sterile immune response
tends to diminish as ATP is converted to adenosine (Corps et al., 2015). Astrocytes and
microglia both express ectoenzymes, needed for the conversion of ATP to adenosine,
giving astrocytes and microglia the ability to reduce ATP-mediated inflammatory
responses (Corps et al., 2015). When neutrophils and T cells are activated, they too release
ATP, which results in stronger activation stimuli for these immune cells (Junger, 2011).
Microglial activation is a key component to neuroinflammation (Tang and Le,
2016), however, the role of microglia activation following CNS injury is not fully
understood and is somewhat controversial. Microglia arrive to the site of trauma within
minutes and their role is dependent on purinergic signaling and astrocyte ATP-dependent
ATP release (Corps et al., 2015). Microglia, considered to be the macrophages of the CNS
(e.g. Perry and Teeling, 2013; Yin, Valin, Dixon, and Leavenworth, 2017), can transform
into phagocytic cells in response to cell death and clear dead and damaged cell debris.
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Depending on the area of damage, microglia may serve additional functions (Corps
et al., 2015). For instance, in the event of damage to the glial limitans, microglia can insert
themselves into the gaps left by dead and injured astrocytes and reinforce this barrier,
preventing material leakage into the parenchyma of the brain (Corps et al., 2015). These
data imply the role of microglia, at least acutely, are mainly beneficial following trauma,
however, other data indicate the presence of microglia following trauma can be detrimental
to the healing process. Microglia can be pushed into overactive states when in the presence
of certain toxins, and damaged/dead neurons. Once that happens, the microglia begin to
overexpress cytotoxic factors (Block, Zecca, and Hong, 2007). One proposed theory
behind the dual functions of microglia (neuroprotective versus cytotoxic or antiinflammatory versus pro-inflammatory) is that there are two distinct phenotypes of
microglia/macrophages.

Phenotype 1 (M1) is sometimes referred to as “pro-

inflammatory” and produces superoxide, nitric oxide, reactive oxygen species (ROS) and
pro-inflammatory cytokines including tumor necrosis factor-α (TNF- α), interleukin-6 (IL6) and interleukin-1β (IL-1β) (Kigerl et al., 2009; Tang and Le, 2016). M1 microglia are
typically found at the sight of injury minutes following trauma and persist for an extended
period of time. In comparison, phenotype 2 (M2) microglia show a smaller and more
fleeting response to injury (Kigerl et al., 2009). M2 microglia promote and aid in
phagocytosis of damaged cells and proteins, angiogenesis, repair of the extracellular
matrix, tissue repair and neuron survival as well as combating the pro-inflammatory
response of the M1 microglia (Kigerl et al., 2009; Tang and Le, 2016). This dichotomy
may be an oversimplification, and some researchers oppose these designations quite
strongly. Distinct M1and M2 phenotypes have only been shown in in vitro experiments
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after exposing macrophages or microglia to specific cytokines (Jassam, Izzy, Whalen,
McGavern, and El Khoury, 2017). Additionally, the actual environment for microglia and
macrophages in the body following trauma is vastly more complicated than this in vitro
model would suggest, limiting the clinical relevance of the M1 versus M2 phenotype
hypothesis. In reality, as opposed to one or two cytokines, microglia following trauma are
surrounded by various cytokines (some upregulated and some downregulated), adhesion
molecules, the surrounding cells and matrix as well as the age of the cell (Jassam et al.,
2017). Evidence indicates that macrophages isolated from TBI animals failed to fall into
distinct phenotypes. In fact, these cells have unique activation states and possess both proinflammatory as well as healing attributes, further complicating the role of microglia
following TBI (Kim, Nakamura, and Hsieh, 2016).
Similar to microglia, the role of neutrophils in the inflammatory response following
TBI is complex and twofold. Neutrophils are typically believed to be pro-inflammatory,
but they can also be beneficial for wound healing by aiding in phagocytosis, the release of
metalloproteinase and the production of growth factors (Corps et al., 2015). Neutrophils
can also play a role in breaking down the BBB and promoting neuronal death following
trauma by releasing proteases, TNF-α and ROS (Corps et al., 2015). Neutrophils are also
involved in the recruitment of monocytes, however the role of monocytes following TBI
is not well understood (Corps et al., 2015). In mice, monocytes can be categorized as either
classical, nonclassical or intermediate. Classical monocytes are believed to infiltrate the
brain following trauma where they differentiate into macrophages, however the role of
nonclassical monocytes is less understood. (Corps et al., 2015; Makinde, Cuda, Just,
Perlman, and Schwulst, 2017).

Briefly, while the global depletion of monocytes was
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correlated with improved outcomes, evidence suggest that both classical and nonclassical
monocytes both play a role in exacerbating damage as well as repairing damage following
trauma (Makinde et al., 2017).
T cells are important for adaptive immunity, however their role following TBI is
unknown (Corps et al., 2015). One study of T cell infiltration in mice following CCI
showed that, while T cells were present in the first day following CCI, peak T cell
infiltration did not occur until day seven following trauma (Clausen et al., 2009).
Interestingly, the same lab two years previously found different results in rats, where peak
infiltration of T cells was seen at 24 hours and slowly decreased through seven days post
injury. Additionally, they found the presence of T cells in the subcortical white matter at
72 hours and at day 7 post injury in a subset of injured animals (Clausen, Lorant, Lewén,
and Hillered, 2007). This indicates there may be differences in the pattern and time course
of T cell infiltration across species (Clausen, 2009; Kelso and Gendelman, 2014), however
these time points may only be applicable in males, as neither female mice nor rats were
used. In mice, it has been shown that females have less immune cell infiltration into the
brain post injury compared to males and this may be responsible for comparatively
diminished neuroinflammatory response in females compared to males following CCI
(Doran et al., 2018). Preclinical evidence suggests that endogenous hormones in female
mice may offer a level of neuroprotection, improving outcome measures post TBI
(Clevenger et al., 2018). Clinical studies have produced mixed findings as to whether TBI
outcomes are different between men and women, with some studies showing better,
equitable, or worse outcomes in women compared to men (reviewed in Clevenger et al.,
2018).
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A concern has also been raised that many studies of T cell infiltration rely on a
marker that is not specific for T cells and labels phagocytes as well (Kelso and Gendelman,
2014). One study found no difference in severity or neurological impairment following
closed head injury in wild-type mice versus Rag1 knockout mice, which lack mature T
cells and B cells, up to a week following injury, indicating T cells do not play a major role
acutely following TBI (Weckbach et al., 2012). However, evidence from transplant studies
potentially offer some support for role of T cells acutely following other types of trauma.
A study utilizing a MPTP model of Parkinson’s disease showed that regulatory T cells
(Treg) were able to attenuate the effects of TH17 cells, a subset of helper T cells that
promotes migration through the BBB that are implicated in autoimmune diseases of the
CNS (Kebir et al., 2007; Reynolds et al., 2010). Whether this is directly translatable to
TBI is unclear. Overall, the current understanding of the role of T cells following TBI is
uncertain and disputed. As the roles of many cells, as well as neuroinflammation in
general, have this dual persona of benefit and damage, attempting to alter the
neuroinflammatory response following TBI is difficult and non-effective (Borgens and
Snyder, 2012; Narayan, 2002; Stahel et al., 2000).
1.5.3

Excitotoxicity
Excitotoxicity refers to glutamate and other related excitatory amino acids

destroying neurons (Olney, 1986). Glutamate is the most abundant excitatory amino acid
in the CNS (Borgens and Snyder, 2012; Yi and Hazell, 2006) and is fairly ubiquitous
throughout the brain in low (millimolar) concentrations, however, when neurons are
exposed to an overabundance of glutamate, they die (Choi, 1992). Astrocytes play a critical
role in maintaining homeostasis in the brain under normal conditions, and in particular play
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a role in glutamate uptake (Kelso and Gendelman, 2014). Under normal circumstances,
glutamate is encapsulated in vesicles in neurons and is released following the influx of
calcium (Ca2+) from depolarizing cells (Borgens and Snyder, 2012; Guerriero, Giza, and
Rotenberg, 2015). Following this release, astrocytes collect up the remaining glutamate, it
is converted to glutamine and returned back to the neurons for glutamate synthesis
(Borgens and Snyder, 2012). In addition to benefitting signal transmission, the clearing of
this extracellular glutamate is vital in preventing excitotoxic damage to the neurons (Floyd
and Lyeth, 2007). Following a TBI, astrocytes become reactive and undergo a functional
(increased expression of GFAP) and conformational change (increased cell size and
elongated projections), but it is unclear if this process is beneficial or harmful (Kelso and
Gendleman, 2014). Shortly following a TBI, there is a massive release of glutamate
(Guerriero et al., 2015). Both human and rodent microdialysis studies have shown an
increase in extracellular glutamate following TBIs (e.g. Bullock et al., 1998; Chamoun,
Suki, Gopinath, Goodman, and Roberston, 2010; Faden, Demediuk, Panter, and Vink,
1989; Folkersma et al., 2011).
In humans with severe TBI, glutamate levels seem to peak within the first 24 hours
post injury and slowly return to baseline, although there is variation between patients with
some having low levels of glutamate throughout the entire studies, some peaking by 24
hours and returning to baseline, some having initially low levels but increasing over time,
and other initially high and either remaining high or increasing over the course of the study
(Chamoun et al., 2010). Patients that either maintained low levels of glutamate or peaked
within 24 hours but returned to normal over the course of the study had better outcomes
and lower mortality rates than patients with glutamate levels that either increased or
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remained abnormally elevated over the course of the study (Chamoun et al., 2010). While
this is interesting, given the heterogeneous nature of TBIs in the clinical population and
the large trial inclusion window (up to 48 hours post TBI), these findings may not be easily
generalizable. Microdialysis studies in rats found peak glutamate levels between 60 and
70 minutes following CCI injury (Folkersma et al., 2011), and around 90 minutes following
FPI (Katayama, Becker, Tamura and Hovda, 1990).
Despite the increases in glutamate seen following TBI in microdialysis studies,
studies utilizing magnetic resonance spectroscopy (MRS) show an overall decrease in
glutamatergic levels following TBI, with an increase in glutamine (Guerriero et al., 2015).
However, this discrepancy is believed to be due to sampling methods as microdialysis
solely measures glutamate in extracellular space where as MRS studies can measure
glutamate stored in vesicles as well as extracellular glutamate (Guerriero et al., 2015). This
overabundance of glutamate in the synapse causes overstimulation of the glutamatergic
receptors which trigger other harmful events that result in necrotic death, such as ion
imbalance from extended depolarization, ATP depletion, and increases in intracellular
levels of Ca2+ (Yin and Hazell, 2006). Taken together, these can cause edema, increase
intracranial pressure, hernia, etc. and these complications can result in the death of the
patient. (Yin and Hazell, 2006). Similarly, when glutamate is administered directly in the
brain, initially neurons and dendrites swell (edema), followed by the shut down and
deterioration of organelles, leading to the neuron becoming necrotic and finally being
phagocytized (Choi, 1992).
Excess glutamate can be caused by various means. Glutamate can be released from
cells following the formation of micropores in the membrane following trauma. Glutamate
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is also able to permeate the brain following trauma-induced BBB disruption (Yi and Hazell,
2006). Some evidence suggests that specific subtypes of glutamate transporters are acutely
down-regulated following trauma, though levels return to normal by 24 hours post injury
(Yi and Hazell, 2006). In addition to this decrease in glutamate transporters, the normal
Na+/K+ gradient is disturbed following TBI, diminishing the capacity of the glutamate
transporters (Yi and Hazell, 2006). The overstimulation of cells caused by excessive
glutamate causes a massive influx of calcium into the neuron (Weber, 2012). Excessive
Ca2+and the activation of Ca2+-dependent enzymes from the over stimulation of glutamate
receptors is believed to be a major contributor to excitotoxicity (Yi and Hazell, 2006).
Proper CNS functioning is heavily dependent on Ca2+signaling and homeostasis (Clapham,
1995; Weber, 2012). Specifically, Ca2+ is involved in neurotransmission (Wojda, Salinska,
and Kuznicki, 2008), development, controlling gene expression, and synaptic plasticity
(Wojda et al., 2008).

In addition to its role in trauma, disrupted Ca2+ homeostasis is

believed to be a component of various neurological and neurodegenerative disorders
(Clapham, 1995; Wojda et al., 2008). Under normal conditions, intracellular levels of Ca 2+
are maintained at approximately 100 nM whereas extracellular concentrations are
maintained around the significantly higher concentration of 1-2 mM (Clapham, 1995;
Weber, 2012). Following TBI, voltage gated calcium channels are activated and this,
combined with Ca2+ leaking into cells through damaged membranes and the release of Ca2+
from intracellular stores, results in elevated intracellular Ca2+ levels (Weber, 2012; Wojda
et al., 2008). This increase in intracellular Ca2+ activates various enzymes that trigger
cascades that result in damage and death to the cells (Trump and Berezesky, 1995; Weber,
2012, Wojda et al., 2008). Excessive intracellular Ca2+ levels are also responsible for
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activating calpains which can break down structural as well as enzymatic components of
the cell (Wojda et al, 2008). One of the endoplasmic reticulum (ER)’s functions is to
sequester intracellular calcium via Ca2+-binding proteins (Clapham, 1995).

The

mitochondria can also store Ca2+, but typically only when Ca2+ levels are pathologically
high (Clapham, 1995).

High levels of Ca2+ in the mitochondria can disrupt the

transmembrane potential, which signals the release of cytochrome c, followed by apoptosis
(Wojda et al., 2008).
Of the ionotropic glutamatergic receptors, N‐methyl‐D‐aspartate (NMDA)
receptors are believed to play the largest role in excitotoxicity as they have higher
permeability to Ca2+ than the others (Yi and Hazell, 2006). Understandably, NMDA
receptor antagonists have gone to clinical trials, but unfortunately none have yielded viable
therapeutic options due to adverse side effects and small therapeutic windows for treatment
(Narayan et al., 2002; Yi and Hazell, 2006). Blockage of the NMDA receptor outside this
narrow therapeutic window can range from ineffective to damaging, as it can inhibit normal
restorative processes (Narayan et al., 2002). In addition to the alteration in glutamatergic
signaling, NMDA receptors themselves are effected following traumatic injury. One study
found that, following CCI, protein levels (as measured by western blot) for the NR1, NR2A
and NR2B were significantly decreased in the hippocampus compared to sham animals at
six and 12 hours post injury, but these levels recovered by the 24-hour mark (Kumar, Zou,
Yuan, Long, and Yang, 2002). Despite this, there was not a similar pattern found for
mRNA expression of these subunits, indicating the change in NMDA subunit is not due to
down regulated gene expression (Kumar et al., 2002). One possible explanation for the
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discrepancy is that these subunits may be decreased due to enzymatic degradation from
calpain (Kumar et al., 2002).

1.6

Medication Development
Primary injury can be prevented or minimized (e.g. use of helmets, enforcement of

speed limits, educating public on dangers of alcohol abuse, etc.), but once a TBI has
occurred, the primary injury is immediate and does not offer a therapeutic window for
treatment (Park et al., 2008; McKee and Daneshvar, 2015). Current treatments for TBI
patients focuses on preventing, minimizing, and/or correcting secondary injury responses
(Park et al., 2008). Unfortunately, almost every medication that has made it to clinical
trials has failed to consistently show efficacy (Xiong, Mahmood, and Chopp, 2009). The
heterogeneous nature of TBIs may be responsible for the lack of effective treatments,
despite promising pre-clinical data (McKee and Daneshvar, 2015; Morales et al., 2005;
Schouten, 2007; Shultz et al., 2017). However, it is also important to consider that animal
models of TBI may not be fully representative of the clinical TBI populations (Morales et
al., 2005). A wide range of drugs have been tested in clinical trials including both
competitive and non-competitive glutamate antagonists, steroids, free radical scavengers,
growth factors, Ca2+ channel blockers, bradykinin antagonists, cannabinoid derivatives,
and anti-convulsants, etc., and have shown inconsistent efficacy, no efficacy, or have even
exacerbated the condition (Narayan et al., 2002; Xiong et al., 2015). While many of these
treatments may truly fail to improve outcomes following TBIs, the design of most of the
trials, a lack of standardization across trials, incorrect or inconsistent outcomes measures
as well as a lack of solid preclinical data may have contributed to the failure of some of
these compounds (Narayan et al., 2002).
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1.7

Alcohol Use Disorder
Alcohol consumption is a risk factor for TBI as between 25% and 51% of patients

with TBIs in the U.S. were intoxicated when the injury took place (Shandro et al., 2009).
Alcohol use and Alcohol Use Disorder (AUD) continue to be major health care concerns
in the United States. As of 2015, an estimated 15.1 million adults and over 600,000
adolescents (ages 12-17) in the U.S. had an AUD (National Survey on Drug Use Health,
2015). Alcohol related deaths are the third preventable cause of death in the U.S., with
alcohol being implicated in 88,000 deaths annually (CDC, 2018), half of which are from
binge drinking (Kanny, Naimi, Liu, Lu, and Brewer, 2018). Alcohol misuse costs the U.S.
an estimated $249 billion annually (Sacks, Gonzales, Bouchery, Tomedi, and Brewer,
2015). The majority of this economic burden is related specifically to binge drinking
(Sacks et al., 2015). While all age groups can engage in binge drinking, binge drinking is
most commonly seen in individuals aged 18-34 years (Kanny et al., 2018). Binge drinking
in young adulthood may be especially concerning as individuals that start drinking at an
early age are at higher risk for developing AUD later in life (Higson, Heeren, and Winter,
2006).

1.8

Risk Factors for AUD
There are several risk factors for the development of AUD. While there is no single

cause of AUD, as with many conditions, evidence supports the interaction of genetic and
environmental factors (Dick, 2011; Hopfer, Crowley, and Hewitt, 2003). While the
definition for AUD keeps evolving, one risk factor is displaying a risky pattern of drinking
behavior (Oscar-Berman and Marinković, 2007). Patterns of risky drinking behaviors can
involve episodes of binge drinking, chronic alcohol use, or both. Risky drinking in males
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has been defined as more than fourteen drinks per week, or more than four drinks per
setting, at least once a month. The definition for risky drinking behavior in women is
similar to men, but at reduced quantities; specifically, ingestion of more than seven drinks
per week or more than three drinks per day, at least once a month (Dawson, Grant, Stinson,
and Zhou, 2005).

1.9

Ethanol Induced Damage
Effects of alcohol are variable based on the amount consumed, time since alcohol

ingestion, pattern of use, as well as several individual factors, such as age, sex, genetics,
family history of drinking, and socioeconomic background (Oscar-Berman and
Marinković, 2007). These individual factors can help to explain why some individuals
with AUD suffer severe, and sometimes permanent, impairments in motor, sensory and
cognitive functions while others with AUD seem to lack any noticeable impairments
(Oscar-Berman and Marinković, 2007). One hypothesis, the premature aging hypothesis,
is that the damage induced by chronic ethanol consumption is comparable to the
neuroanatomical changes seen in aging (reviewed in Oscar-Berman and Marinković,
2007). Generally, both chronic alcohol use and normal aging result in atrophy of the frontal
lobes, enlargement of ventricles, as well as increased width of sulci (Oscar-Berman and
Marinković, 2007; Sullivan and Pfefferbaum, 2013). Several imaging studies have shown
additional abnormalities following chronic ethanol consumption including a reduction in
volume of limbic structures (thalamus, mammillary bodies, anterior hippocampus), striatal
structures (caudate and putamen), as well as the cerebellar hemispheres and the vermis in
individuals with a history of chronic alcohol use (reviewed in Sullivan and Pfefferbaum,
2013).

Not surprisingly, individuals with Wernicke-Korsakoff’s Syndrome (WKS)
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showed an even greater loss of volume than individuals with a history of chronic alcohol
use without WKS (Sullivan and Pfefferbaum, 2009).
In addition to loss of volume in several important structures, studies utilizing
diffusion tensor imaging (DTI) have shown individuals with a history of alcohol use show
compromised integrity of the corpus callosum and of the centrum semiovale (Sullivan and
Pfefferbaum, 2013).

In fact, alcohol-induced damage to white matter structures is

correlated with specific cognitive deficits seen in individuals with a history of chronic
alcohol use. Specifically, higher diffusivity in the genu is correlated with decreased
working memory and higher diffusivity in the splenium is correlated with impairments in
a spatial reasoning task (Pfefferbaum, Adalsteinsson, and Sullivan, 2006).

Mean

diffusivity measures water diffusion in the brain tissue. Normally, cell barriers serve to
restrict the diffusion of water, however, in many disease states as well as chronic alcohol
use, these naturally occurring barriers can become compromised, resulting in higher
diffusivity (Clark et al., 2011). In addition to corpus callosum white matter tracts, a
studying using quantitative fiber tracking found that men with a history of chronic alcohol
use show up to an 18% reduction in white matter tracts per volume between the midbrain
and pons when compared to control men (Chanraud et al., 2009). This reduction is
correlated with impaired performance on Trail-Making Test Part B, a task believed to
measure cognitive flexibility (Kortte, Horner, and Windham, 2002; Chanraud et al., 2009).
These changes in neuroanatomy following chronic alcohol use account for the neurological
impairments seen in individuals with a history of alcohol use (Bernardin, Maheut-Bosser,
and Paille, 2014; Chanraud et al., 2007). Although individuals with a history of chronic
alcohol use show damage in various areas of the brain, the frontal lobes seem to be
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especially vulnerable to ethanol induced damage and can show anatomical abnormalities
(e.g. cerebral atrophy, and reduction in blood flow and glucose utilization) before cognitive
and executive function becomes noticeably compromised (for review, see Moselhy,
Georgiou, and Khan, 2001). Although some may not show noticeable cognitive deficit at
least initially, other individuals with AUD can show significant impairment in executive
functions. For example, one study showed that individuals meeting criteria for alcohol
dependence (DSM-IV) showed impairments in the Trail Making Test Part B, the Wallace
Adult Intelligence Scale-letter-number sequencing, and in the Wisconsin Card Sort Task.
These tasks assess an individual’s cognitive flexibility, working memory, and abstract
thinking and ability to understand and alter responses based on feedback, respectively
(Chanraud et al., 2007). However, they also found that these alcohol dependent individuals
did not differ from control participants on the Letter Fluency Test, a measure of verbal
fluency, or on The Stroop Color Word test, which assesses an individual’s selective
attention, ability to ignore interfering stimuli and the speed of cognitive processing
(Chanraud et al., 2007). Another study also showed that heavier alcohol consumption was
associated with poorer scores on the Dysexecutive Functioning Questionnaire, Trail
Making Task (part A and B), the GoStop Task, and the Wisconsin Card Sort, but no
difference in the Digit Span task or the Stroop Interference task (Houston et al., 2014).
In addition to these neuroanatomical deficits previously discussed, fMRI studies
show that, even when individuals with a history of alcohol use perform a task without
noticeable impairments from control participants, they display a different pattern of brain
activity. In general, when given tasks, they use alternative pathways, more widespread
areas, or both (reviewed in Sullivan and Pfefferbaum, 2013). These differing patterns of
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activation support the inefficient processing hypothesis, which suggest that individuals
with a history of chronic alcohol use have to activate and recruit more regions of their brain
to perform a task the same as a control participant (Nixon, Tivis, Ceballos, Varner, and
Rohrbaugh, 2002; Sullivan and Pfefferbaum, 2013).
A factor in the neurodegeneration caused in people with a history of alcohol
dependence is the pattern of use followed by abstinence (Duka et al., 2004; Mello and
Mendleson 1972). Additionally, the pattern of withdrawals leads to the neuroadaptations
(Duka et al., 2004). Chronic use of alcohol causes increased expression of NMDA receptor
as well as increasing the function of the NMDA receptor (Chandrasekar, 2013). Following
chronic alcohol exposure, the glutamatergic system goes to a sensitized or hyperactive state
and this can lead to some of the damage previously listed with this excitotoxic mechanism
(Lovinger, 1993). Given that excitotoxicity is already a mechanism of secondary injury
seen following traumatic brain injury (e.g. Bullock et al., Chamoun et al., 2010; Faden et
al., 1989, Folkersma et al., 2011; Guerriero et al., 2015), it is possible that individuals with
a history of this pattern of alcohol use followed with withdrawal may be sensitized to the
effects of excitotoxicity.

1.10 Alcohol Use Prior to TBI
Alcohol is a major risk factor for injuries, including TBIs (Kolakowsky-Hayner et
al., 1999; Shandro et al., 2009). While blood alcohol levels are not always collected for
TBI patients, when these measures are taken, between 25% and 51% of TBI patients are
intoxicated at the time of the injury (for reviews see Corrigan, 1995; Shandro et al., 2009).
While this is quite a large range, studies examining blood alcohol concentration (BAC),
have shown a bimodal distribution, with studies clustering around 35% and 50% of TBI
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patients were intoxicated at the time of the injury (Corrigan, 1995). Part of the discrepancy
could be due to the lack of testing for blood alcohol levels in all patients. There is evidence
to suggest a bias in which patients are have their blood alcohol levels measured. Patients
that are dead on the scene had their blood alcohol levels tested 93% of the time and patients
that arrived at the hospital dead had their blood alcohol levels tested 99% of the time
(Kraus, Morgenstern, Fife, Conroy, and Nourjah, 1989). However, among survivors of
TBIs, they found a marked difference in prevalence of testing based on severity of injury.
Patients suffering from severe TBIs (GCS of 8 or less) had their blood alcohol levels tested
61% of the time, patients with moderate TBIs (GCS 9-12) had their blood alcohol levels
tested 54% of the time, but patients with mild TBIs (GCS 13-15) only had their blood
alcohol levels tested 30% of the time (Kraus et al., 1989). The rates of intoxication reported
for TBIs are also impacted by the BAC level used to define “intoxication” in these studies.
Many studies examining the prevalence of alcohol intoxication at the time of TBI used a
BAC of 0.1 or greater as their definition of intoxication (e.g. Gurney et al., 1992; Kraus et
al., 1989; Lange, Iverson, and Franzen, 2007; Lin et al., 2014; Sparadeo and Gill, 1989).
Many of these studies were prior to the federal initiative to lower the legal limit to 0.08 for
illegal operation of a motor vehicle (National Highway Traffic Safety Administration,
2000) or use archival data from before this switch. However, impairments may be seen at
much lower blood alcohol concentrations than 0.1 (National Highway Traffic Safety
Administration, 2016; Shanin and Robertson, 2012), so the operational definitions of
intoxication may muddy the results as well. Another potential confound is the time the
blood is drawn for TBI patients in regards to time of injury (Shandro et al., 2009). While
there are many factors impacting the absorption and metabolism of alcohol (for review see
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Cederbaum, 2012), if blood alcohol levels are not taken at the time of the injury, readings
will be artificially lowered, confounding the results of these studies.
Given the number of individuals that are intoxicated at the time of their injury, it is
important to understand how alcohol impacts patient outcomes and mortality. First and
foremost, it is vital to recognize that, regardless of the effects of alcohol on outcomes,
intoxication is considered the predominant risk factor for sustaining a TBI (KolakowskyHayner et al., 1999). There is no consensus on how alcohol consumption before injury or
intoxication at the time of injury affects TBI prognosis. Several studies have found that
alcohol intoxication at the time of injuries is associated with worse outcomes. Specifically,
intoxication has been correlated with increased likelihood of severe computerized
tomography (CT) scan lesions (Cunningham, Maio, Hill, and Zink, 2002) and more
severely graded TBIs (Scheene et al., 2016), worse cognitive outcomes (Joseph et al., 2015;
Mathias and Osborn, 2018), increased complications such as intubation, intracranial
pressure monitoring, and surgical intervention (Gurney et al., 1992; Pandit et al., 2014;
Shahin and Robertson, 2012), longer hospital stays, increased need for rehabilitation
(Pandit et al., 2014), higher levels of disability (Mathias and Osborn, 2018) and increased
mortality (Pandit et al., 2014; Ruff et al., 1990) compared to sober patients. Additionally,
a study from India also found that TBI patients that used alcohol had TBIs that were more
severe, had longer hospitalizations, and worse outcomes than patients that did not use
alcohol (Gururaj, 2004). However, other studies have found there to be no difference
between sober and intoxicated patient in terms of neuropsychological outcomes (e.g.
Dikmen, Donovan, Løberg, Machamer, and Temkin, 1993; Lange et al., 2014; Lange,
Iverson, and Franzen, 2008) no effect of intoxication on outcomes aside from very subtle
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cognitive differences (Mathias and Osborn, 2018), and no effect on mortality in hospital,
90 days post injury, or one-year post injury (Shandro et al., 2009). Additionally, other
studies have shown that patients who were intoxicated at the time of injury actually fared
better than patients that were sober at the time of injury. Patients that were intoxicated at
the time of injury have shown the same or better cognitive function (Lange et al., 2008),
better outcomes two weeks following injury (Scheenen et al., 2016) and lower rates of
mortality than sober TBI patients (Berry et al., 2011; Raj et al., 2015). A trend has also
been shown that increasing BACs are correlated with improved survival, decreased
likelihood of intensive care unit (ICU) admission and shorter ICU and hospital stays (Berry
et al., 2011). Tien and colleagues (2006) conducted a retrospective study and found that
individuals with moderate blood alcohol levels (operationally defined as a BAC between
0 and 230 mg/dL) had lower in-hospital mortality rates than individuals with a BAC of 0
at the time of injury. There was a non-statistically significant trend (p=.10) for patients
with high BACs (BAC greater than 230 mg/dL) having a higher rate of in-hospital
mortality than individuals with a BAC of 0 (Tien et al., 2006). There was also a trend for
individuals with high BACs to die earlier in their hospital stays than individuals with a
BAC of 0 (Tien et al., 2006).
While a few of these studies may seem to support the theory that acute alcohol
intoxication may be neuroprotective at the time of TBI, the nature of these studies prevents
conjectures about causality and some studies only looked at acute mortality or outcomes,
which may not accurately represent the full picture. However, the speculation that low to
moderate doses of alcohol at the time of injury may be neuroprotective via the inhibition
of NMDA receptors and a subsequent dampening of the excitotoxicity following a TBI is
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not without reason (Opreanu, Kuhn, and Basson, 2010). Preclinical trials of glutamate
antagonists (e.g. Selfotel, Cerestat, CP 101-606) have shown efficacy in preclinical studies,
but have not been shown effective in clinical trials (Narayan et al., 2002). There are many
possible explanations for this discrepancy. Many of these trials suffered from design flaws,
making it difficult to draw conclusions about the promise of the proposed mechanism of
action (Narayan et al., 2002). However, one main difference between preclinical and
clinical studies was the timeframe in which the drugs were administered. In preclinical
trials, pharmaceutical intervention is typically given as a pretreatment or given soon after
injury, but in clinical trials, medication is not able to be given until several hours after
injury (Daiz-Arrastia et al., 2014; Mohamadpour, Whitney and Bergold, 2019; Narayan et
al., 2002; Shohami and Biegon, 2014). Ideally, potential medications need to be effective
at least 12 hours after injury (Mohamadpour et al., 2019). The gap between ideal and
realistic therapeutic windows is not unique to glutamatergic agents and has plagued almost
all medications (with various mechanisms of action) in TBI clinical trials, including
Cyclosporine A (Sullivan, Sebastian, and Hall, 2011), progesterone (Skolnick et al., 2014;
Wright et al., 2014), ziconotide and CDP-choline (Mohamadpour et al., 2019). In addition
to the small therapeutic window for intervention, agents that inhibit glutamatergic signaling
have additional complications.
Although there may be a benefit of NMDAr inhibition immediately following a
TBI, the proposed benefit of alcohol in limiting excitotoxicity is subject to the same narrow
therapeutic window NMDAr antagonists face (Shohami and Biegon, 2014). In fact,
depending on the time since injury, it can be more beneficial to administer an NMDAr
agonist (Biegon et al., 2004). After the initial, and fleeting, increase in glutatmatergic
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activity following a TBI, there is a loss of NMDA receptors and those that remain are
desensitized (e.g. Biegon et al., 2004; Grossman et al., 2003). In addition to not improving
outcomes after TBIs, administration of NMDAr antagonist may even hinder the recovery
process (Shohami and Biegon, 2014). Given the confusion surrounding the influence of
alcohol on TBIs, the circumstances through which alcohol may improve or exacerbate TBI
damage are important to understand.
The purpose of these studies is to characterize a model for studying the interaction of
alcohol and TBIs in a hippocampal slice culture method. Using hippocampal slices allows
understanding of the interaction of alcohol and TBIs and potential cellular mechanisms that
may be beneficial in preventing or treating the secondary injury mechanisms. The purpose
of experiment 1 is determine the effect of alcohol intoxication at the time of injury on cell
death in hippocampal slice cultures. It is hypothesized that ethanol intoxication at the time
of injury will result in more cell death compared to slices that are given a TBI in control
media. However, the clinical data offers conflicting reports on the effects of alcohol
intoxication and it is possible that ethanol intoxication at the time of injury may not have
an effect or be neuroprotective compared to the TBI alone group. The purpose of
experiment 2 is to determine how ethanol withdrawal at the time of injury will affect cell
death in hippocampal slice cultures. It is hypothesized that ethanol withdrawal prior to a
TBI will result in more cell death in the slices compared to the slices that receive a TBI in
control media. The rationale is that the ethanol withdrawal will cause sensitization of the
NMDA receptors at the time of the TBI and exacerbate the excitotoxicity seen following
TBIs. The purpose of experiment 3 is to determine how a calpain inhibitor (MDL) prior to
injury will affect cell death in hippocampal slice cultures. It is hypothesized that MDL will
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reduce the amount of cell death in the group administered MDL prior to the TBI compared
to the group that is administered the TBI in control media by inhibition of calpains.
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CHAPTER 2. METHODS
2.1

Hippocampal Slice Culture
Eight-day old male and female Sprague Dawley pups (Harlan Laboratories;

Indianapolis, IN) were humanely euthanized and their brains were harvested using aseptic
technique. After removal, the brains were placed into cold dissecting media containing
Minimum Essential Media (MEM; Invitrogen, Carlsbad, CA), (4-(2-hydroxyethyl)-1piperazineethanesulfonic acid) (HEPES; Sigma, St. Louis, MO), streptomycin/penicillin
(Invitrogen) and Amphotericin B solution (Sigma). The brains were cut midsagittally and
the hippocampi removed. Any excess tissue was cleared from the hippocampi using a
scalpel. Cleaned hippocampi were then chopped from front to back into slices 200 µm
thick using a McIllwain Tissue Chopper (Mickle Laboratory Engineering Co. Ltd.,
Gomshall, UK). Slices were then selected for culturing. Slices were only selected for
culturing if they had all three of the major regions of the hippocampus intact (the CA1, the
CA3, and the dentate gyrus (DG)). These slices were then plated onto biopore membrane
inserts with three to four slices per membrane. Slices were plated in such a way to ensure
enough space to prevent overlapping of the slices. Any excess media surrounding the slice
was drawn up with a pipette to keep the slice from drowning. These inserts were then
placed into six-well plates that contained approximately 1milliliter of culture media in the
bottom. Slices were incubated for 5 days prior to any treatment to allow them to adhere to
the membrane surface and to allow for damage from dissection to heal. Following the
treatment(s), slices were imaged for cytotoxicity using Propidium Iodide (PI) stain. Slices
were then fixed with a 10% formalin solution.

2.2

Experiment I: Ethanol Intoxication Prior to TBI
After 5-days in vitro, inserts containing the hippocampal slice cultures were

transferred to new six-well plates. Cultures were randomly assigned to control or ethanol
media (50mM, approximately equivalent to a blood alcohol level of .23). Plates with
control media were placed into a Tupperware container with 50mL of distilled water and
then placed into a Ziploc bag, filled with 5% CO 2 and 95% air, and then sealed. Slices
treated with ethanol media were similarly placed in a Tupperware container with 50 mL of
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50mM ethanol, placed in a Ziploc bag filled with 5% CO 2 and 95% air, and then sealed.
Cultures were then placed in the incubator for an additional five days. At 10 days in vitro,
all tissue was placed into new six-well plates with either control or ethanol media (50mM)
media containing 7.48 µM PI. TBIs were administered to one-half of the cultures in the
control media and in the ethanol media. Tissue receiving a TBI was placed under a
stereoscope for easier identification of the CA1 region. TBI administration was done via
a single cut into the CA1 region of the hippocampus with No. 15 blade scalpel. If the cut
did not hit the CA1, if the cut hits the CA3 or dentate gyrus, or if multiple cuts were made
into the tissue, that slice was not included in the analyses. Following the TBI procedure,
tissue was placed in Tupperware containers with either 50mL of distilled water or 50mM
ethanol, placed in Ziploc bags and filled with 5% CO 2 and 95% air, then sealed before the
tissue was returned to the incubator. Tissue was imaged at 24, 48, and 72 hours post TBI.
Following imaging at the 72-hour time point, tissue was fixed with a 10% formalin solution

2.3

Experiment II: Ethanol Withdrawal Prior to TBI
After 5-days in vitro, inserts containing the hippocampal slice cultures were

transferred to new six-well plates. Cultures were randomly be assigned to control or
ethanol media (50mM, approximately equivalent to a blood alcohol level of .23). Plates
with control media were then placed into a Tupperware container with 50mL of distilled
water and placed into a Ziploc bag, filled with 5% CO2 and 95% air, and then sealed. Slices
treated with ethanol media were similarly placed in a Tupperware container with 50 mL of
50mM ethanol, placed in a Ziploc bag filled with 5% CO2 and 95% air, and then sealed.
Cultures were then placed in the incubator for an additional five days. At 10 days in vitro,
all tissue was placed into new six-well plates with control media containing 7.48 µM PI.
Tissue was then returned to the incubator for an additional 24 hours to induce ethanol
withdrawal. After 24-hour withdrawal, TBIs were administered to one-half of the cultures
in the control media and in the ethanol media. Tissue that received a TBI was placed under
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a stereoscope for easier identification of the CA1 region. TBI administration was done via
a single cut into the CA1 region of the hippocampus with No. 15 blade scalpel. If the cut
did not hit the CA1, if the cut hit the CA3 or dentate gyrus, or if multiple cuts were made
into the tissue, that slice was not included in the analysis. Following the TBI procedure,
tissue was placed in the incubator. Tissue was imaged at 24, 48, and 72 hours post TBI.
Following imaging at the 72-hour time point, tissue was fixed with a 10% formalin
solution.

2.4

Experiment III: Influence of Calpain Inhibition on TBI Induced Cell Death
After 5-days in vitro, inserts containing the hippocampal slice cultures were

transferred to new six-well plates. Cultures were randomly assigned to control or TBIs.
Plates were placed into a Tupperware container with 50mL of distilled water and then
placed into a Ziploc bag, filled with 5% CO2 and 95% air, and then sealed. Cultures were
then placed in the incubator for an additional five days. At 10 days in vitro, all tissue was
placed into new six-well plates with control media and returned to the incubator for 24
hours to account for lack of withdrawal time. Then, half of the tissue in the Control and
half of the tissue in the TBI group were place in either control media containing 7.48 µM
PI or media containing 7.48 µM PI and MDL-28170 (25 µM) and returned to the incubator
for two hours.
administered.

Following this two-hour incubation with MDL-28170, TBIs were
Tissue receiving a TBI was placed under a stereoscope for easier

identification of the CA1 region. TBI administration was done via a single cut into the
CA1 region of the hippocampus with No. 15 blade scalpel. If the cut did not hit the CA1,
if the cut hit the CA3 or dentate gyrus, or if multiple cuts were made into the tissue, that
slice was not included in the analysis. Following the TBI procedure, tissue was placed in
the incubator. Tissue was imaged at 24, 48, and 72 hours post TBI. Following imaging at
the 72-hour time point, tissue was fixed with a 10% formalin solution.

42

2.5

Staining of Cultures with Propidium Iodide
During final treatments of tissue, Propidium Iodide (PI) is added to culture media at

7.48µM concentration. PI is a highly polar fluorescent compound (Zimmer, Kristensen,
Jakosen, and Noraberg, 2000) which used as a marker of cell membrane integrity and
indirectly as a measure of cell death (Cummings, Willis, and Schnellmann, 2004) and
correlates with other measures of cell death (Wilkins et al., 2006). As PI is a polar
compound, it can only enter cells that have a compromised cell membrane (dead or dying
cells), it then binds to the cell’s nucleic acids (DNA) and gives off a fluorescent signal
(Macklis and Madison, 1990). Cell cultures were then be imaged using a Leica DMIRB
microscope (W. Nuhsbahm Inc.; McHenry, IL, USA) capable of detecting fluorescence
(via mercury lamp) under a 5x objective lens. The microscope is connected to a computer
with SPOT advanced software for Windows (version 4.0.2) through a SPOT 7.2 color
mosaic camera (W. Nuhsburg). The optical density of these fluorescent images was then
quantified using Image J software (National Institutes of Health, Bethesda, MD). For
optical density, three regions of the hippocampus were assessed- the CA1, CA3, and the
dentate gyrus. Prior to assessment of these areas of interest, a measure of background
optical density was taken for each slice. This background measurement was subtracted
from each measure of optical density for that slice prior to analysis. To account for
potential variability, all optical density measurements were normalized to a percentage of
control, using the formula (S-B)/C where S is the intensity of a region of a given slice, B
is the background value from that image, and C is the mean fluorescent value for the control
slices (see Mulholland et al., 2005). Image J software was also be used to quantify the area
of trauma in the CA1 in slices that are subjected to TBI treatments. Following the final
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imaging, the slices were preserved by fixing in a 10% formalin solution then stored at 4
degrees Celsius.

2.6

Statistical Analysis
Statistical analyses were conducted to determine the effect of treatment (e.g.

Control, Ethanol, TBI, etc.) on severity of cell death in specific regions of the hippocampus.
Cultures were also assessed for sex effects. Data were assessed in SPSS (version 24) using
a Two Factor ANOVA (Treatment x Sex), with significance level set at p ≤ 0.05 and, if
appropriate, post hoc analyses were conducted using Fisher’s Least Significant Difference
(LSD).

Figure 2.1 Transection Model. Left: Representative image of transection model of
traumatic brain injury in hippocampal slice culture. A single cut was administered with a
No. 15 scalpel near the midpoint of the CA1 of the hippocampus. Right: Simplified
drawing of transection model of TBI for clarity.
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CHAPTER 3. RESULTS
3.1
3.1.1

Experiment I: Ethanol Intoxication Prior to TBI
Effect of Treatment
3.1.1.1 24 Hour
There was a main effect of treatment in the CA1 region at 24 hours, F(3,170) =

32.63, p < .001 (Figure 3.1.1). Both the TBI (M = 206.99, SE = 10.54) and EtOH+TBI (M
= 194.84, SE = 10.41) groups showed more cell death compared to slices in the control
condition (M = 100.00, SE = 9.72), p < .001. However, there was no difference in cell
death between slices in the EtOH treated group (M = 102.02, SE = 9.824) and slices in the
control condition (M = 100.00, SE = 9.72), p = .884. There was no difference in cell death
between slices that were kept in ethanol prior to the TBI (EtOH+TBI) compared with slices
that were kept in control media prior to the TBI, p = .413. There was no effect of treatment
on the CA3 (Figure 3.1.2) or the DG (Figure 3.1.3) regions of the hippocampal slices at the
24-hour time point, F(3,170) = 0.93, p = .427 and F(3,170) = 0.716, p = .544, respectively.
3.1.1.2 48 Hour
There was an effect of treatment in the CA1 region at the 48-hour time point,
F(3,170) = 29.554, p < .001 (Figure 3.2.1). Both the TBI (M = 175.63, SE = 7.79) and
EtOH+TBI (M = 166.12, SE = 7.70) groups showed more cell death compared to slices in
the control condition (M = 100.00, SE = 7.19), p < .001. There was no difference between
slices in the EtOH groups (M = 101.24, SE = 7.26) and slices in the control condition (M =
100.00, SE = 7.19), p = .903. There was no difference in cell death between slices in the

45

EtOH+TBI group and the TBI group, p = .386. There was no effect of treatment in the
CA3 (Figure 3.2.2) or DG (Figure 3.2.3) regions, F(3, 170) = 1.50, p = .217 and F(3,170)
= 0.95, p = .418.
3.1.1.3 72 Hour
There was an effect of treatment in the CA1 region at the 72-hour time point,
F(3,170) = 21.64, p < .001 (Figure 3.3.1). Both the TBI (M = 161.10, SE = 6.80) and
EtOH+TBI (M = 147.15, SE = 6.71) groups had more cell death compared with slices in
the control condition (M = 100.00, SE = 6.27), p < .001. There was no difference between
slices in the EtOH group (M = 104.84, SE = 6.34) and slices in the control group (M =
100.00, SE = 6.27), p = .588. There was no difference between slices in the TBI condition
and slices in the EtOH+TBI condition, p = .146. There was no effect of treatment in the
CA3 (Figure 3.3.2) or DG (Figure 3.3.3) regions of the hippocampal slices, F(3,170) =
0.81, p = .490 and F(3,170) = 0.35, p = .791, respectively.

3.1.2

Effect of Sex
3.1.2.1 24 Hour
There was not a sex difference in the CA1, F(1,170) = 0.19, p = .661 (Figure 3.1.1),

the CA3, F(1,170) = 1.30, p = .255 (Figure 3.1.2), or the DG, F(1,170) = 0.45, p = .504
(Figure 3.1.3).
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3.1.2.2 48 Hour
There was not a sex difference in the CA1, F(1,170) = 2.55, p = .112 (Figure 3.2.1).
However, there was a sex difference in the CA3 (Figure 3.2.2) and DG (Figure 3.2.3)
regions of the hippocampus, F(1,170) = 4.07, p = .045 and F(1,170) = 3.95, p = .049,
respectively. In the CA3, female slices (M = 112.87, SE = 6.53) had more cell death on
average compared to male slices (M = 94.25, SE = 6.52). The same pattern was seen in the
DG, with the female slices (M = 114.67, SE 6.00) had more cell death on average compared
with the male slices (M = 97.84, SE = 5.99).
3.1.2.3 72 Hour
There was not a sex difference in the CA1, F(1,170) = 0.08, p = .774 (Figure 3.3.1),
the CA3, F(1,170) = 0.82, p = .366 (Figure 3.3.2), or the DG, F(1,170) = 0.15, p = .699
(Figure 3.3.3).

3.2
3.2.1

Experiment II: Ethanol Withdrawal Prior to TBI
Effect of Treatment
3.2.1.1 24 Hour
There was an effect of treatment in the CA1 at the 24-hour time point, F(3,338) =

95.07, p < .001 (Figure 3.4.1). The EWD (M = 132.12, SE = 7.42), TBI (M = 236.57, SE
= 7.77), and EWD+TBI (M = 252.47, SE = 7.77) all had more cell death compared with
the control group (M = 100.00, SE = 7.86), p = .003, p < .001, and p < .001, respectively.
There was no difference between slices in the TBI condition and slices in the EWD+TBI
condition, p = .149. Similarly, in the CA3, there was an effect of treatment, F(3,338) =
47

4.46, p = .004 (Figure 3.4.2). The EWD (M = 128.50, SE = 7.19), TBI (M = 129.76, SE =
7.52), and EWD+TBI (M = 135.78, SE = 7.52) all had more cell death compared with the
control group (M = 100.00, SE = 7.61), p = .007, p = .006, and p = .001, respectively. There
was no difference between slices in the TBI and EWD+TBI groups, p = .571. In the DG,
the same pattern was seen. There was a main effect of treatment, F(3,338) = 4.42, p = .005
(Figure 3.4.3). The EWD (M = 127.75, SE = 7.87), TBI (M = 135.39, SE = 8.23), and
EWD+TBI (M = 138.12, SE = 8.23) all had more cell death compared with the control
group (M = 100.00, SE = 8.33), p = .016, p = .003, and p = .001, respectively. There was
no difference between the TBI and the EWD+TBI conditions, p = .815.
3.2.1.2 48 Hour
There was an effect of treatment in the CA1 at the 48-hour time point, F(3,338) =
49.28, p < .001 (Figure 3.5.1). The EWD (M = 129.75, SE = 6.462), TBI (M = 196.17, SE
= 6.77), and EWD+TBI (M = 192.61, SE = 6.76) groups all had more cell death compared
with the slices in the control group (M = 100.00, SE = 6.84), p = .002, p < .001, and p
<.001, respectively. There was no difference between the TBI and EWD+TBI group, p =
.710. Similarly, in the CA3, there was an effect of treatment, F(3,338) = 4.60, p = .004
(Figure 3.5.2). The EWD (M = 135.89, SE = 9.162), TBI (M = 139.90, SE = 9.59), and
EWD+TBI (M = 145.95, SE = 9.59) groups all had more cell death compared with the
slices in the control group (M = 100.00, SE = 9.70), p = .008, p = .004, and p = .001,
respectively. There was no effect of treatment in the DG at the 48-hour time point,
F(3,338) = 2.23, p = .084 (Figure 3.5.3).
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3.2.1.3 72 Hour
The was an effect of treatment in the CA1 at 72 hours, F(3,338) = 15.92, p < .001
(Figure 3.6.1). Both the TBI (M = 129.51, SE = 4.97) and EWD+TBI (M = 144.60, SE =
4.97) had more cell death than the control condition (M = 100.00, SE = 5.03), p < .001.
There was no difference between the EWD group (M = 110.61, SE = 4.75) compared with
the control group (M = 100.00, SE = 5.03), p = .126. Additionally, there was significantly
more cell death in the EWD+TBI group compared with the TBI group, p = .032. In the
CA3, there was an effect of treatment, F(3,338) = 2.92, p = .034 (Figure 3.6.2). The
EWD+TBI group (M = 126.01, SE = 8.11) had more cell death than the control condition
(M = 100.00, SE = 8.21), p = .025 and more cell death than the TBI alone condition, p =
.025. Neither the EWD condition (M = 121.50, SE = 7.76) or the TBI condition (M =
100.12, SE = 8.12) differed from the control condition (M = 100.00, SE = 8.21), p = .058
and p = .992, respectively. In the DG, there was an effect of treatment, F(3,338) = 6.12, p
< .001 (Figure 3.6.3). Both the EWD (M = 135.61, SE = 7.44) and EWD+TBI (M = 126.66,
SE = 7.78) conditions had more cell death compared to the control condition (M = 100.00,
SE = 7.88), p = .001 and p = .017, respectively. The TBI group (M = 97.87, SE = 7.78) did
not differ from the control condition (M = 100.00, SE = 7.88), p = .848. Additionally, the
EWD+TBI condition had more cell death compared to the TBI alone condition, p = .009.
3.2.2

Effect of Sex
3.2.2.1 24 Hour
There was an effect of sex in the CA1 (Figure 3.4.1) and CA3 (Figure 3.4.2) regions

of the hippocampus, F(1,338) = 7.88, p = .005 and F(1,338) = 5.57, p = .019, respectively.
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In the CA1, the female slices (M = 191.10, SE = 5.48) showed more cell death on average
compared with the male slices (M = 169.47, SE = 5.42). Similarly, in the CA3, the female
slices (M = 132.31, SE = 5.31) had more cell death than the male slices (M = 114.70, SE =
5.25). In the DG, there was no effect of sex, F(1,338) = 2.37, p = .124 (Figure 3.4.3).
3.2.2.2 48 Hour
There was an effect of sex in the CA1 region at the 48-hour time point, F(1,338) =
6.95, p = .009 (Figure 3.5.1). The female slices (M = 163.48, SE = 4.77) had more cell
death on average compared with male slices (M = 145.79, SE = 4.72). There was no effect
of sex in the CA3 (Figure 3.5.2) or DG (Figure 3.5.3) regions at the 48-hour time point,
F(1,338) = 0.102, p = .749 and F(1,338) = 0.18, p = .674.
3.2.2.3 72 Hour
There was no effect of sex at 72 hours in the CA1, F(1,338) = 2.96, p = .086 (Figure
3.6.1), CA3, F(1,338) = 0.02, p = .890 (Figure 3.6.2), or the DG, F(1,338) = 2.05, p = .153
(Figure 3.6.3).

3.3
3.3.1

Experiment III: Influence of Calpain Inhibition on TBI Induced Cell Death
Effect of Treatment
3.3.1.1 24 Hours
There was an effect of treatment in the CA1 at 24 hours, F(3,181) = 45.28, p < .001

(Figure 3.7.1). Both the TBI (M = 202.12, SE = 8.14) and MDL+TBI (M = 184.87, SE =
8.34) conditions had more cell death than the control condition (M = 100.00, SE = 8.24), p
< .001. The MDL group (M = 97.51, SE = 8.14) was not different from the control
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condition (M = 100.00, SE = 8.24), p = .830. There was no difference between the TBI
and MDL+TBI conditions, p = .141. In the CA3, there was an effect of treatment, F(3,181)
= 2.78, p = .043 (Figure 3.7.2). The TBI group (M = 129.76, SE = 8.26) had more cell
death than the control condition (M = 100.00, SE = 8.36), p = .012. There was no difference
between either the MDL (M = 106.68, SE = 8.26) or MDL+TBI (M = 123.12, SE = 8.46)
compared to the control condition (M = 100.00, SE = 8.36), p = .571 and p = .054,
respectively. There was no effect of treatment in the DG at 24 hours, F(3,181) = 2.63, p =
.052 (Figure 3.7.3).
3.3.1.2 48 Hours
There was an effect of treatment in the CA1 at 48 hours, F(3,181) = 37.81, p < .001
(Figure 3.8.1). Both the TBI (M = 173.30, SE = 6.72) and MDL+TBI (M = 166.52, SE =
6.88) conditions had more cell death compared to the control condition (M = 100.00, SE =
6.79), p < .001. There was no difference between the MDL condition (M = 96.12, SE =
6.72) and the control condition (M = 100.00, SE = 6.79), p = .685. There was no difference
between the TBI and MDL+TBI groups, p = .481. In the CA3, there was an effect of
treatment, F(3,181) = 3.12, p = .028 (Figure 3.8.2). The TBI group (M = 128.80, SE =
7.65) had more cell death than the control condition (M = 100.00, SE = 7.73), p = .009.
Neither the MDL (M = 104.00, SE = 7.65) or the MDL+TBI group (M = 120.32, SE = 7.83)
differed from the control condition (M = 100.00, SE = 7.73), p = .713 and p = .067,
respectively. There was no difference between the TBI and MDL+TBI groups, p = .440.
There was an effect of treatment in the DG at 48 hours, F(3,181) = 3.17, p = .026 (Figure
3.8.3). The TBI condition (M = 129.30, SE = 6.69) had more cell death than the control
condition (M = 100.00, SE = 6.76), p = .002. Neither the MDL (M = 115.02, SE = 6.69) or
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MDL+TBI (M = 115.95, SE =6.85) differed from the control condition (M = 100.00, SE =
6.76), p =.116 and p = .099, respectively. There was no difference between the TBI and
MDL+TBI groups, p = .165.
3.3.1.3 72 Hours
There was an effect of treatment in the CA1 at 72 hours, F(3,181) = 34.03, p < .001
(Figure 3.9.1). Both the TBI (M = 169.50, SE = 6.41) and MDL+TBI (M = 172.42, SE =
6.57) groups had more cell death than the control condition (M = 100.00, SE = 6.49), p <
.001. There was no difference between the MDL (M = 112.25, SE = 6.41) and control
conditions (M = 100.00, SE = 6.49), p = .181. There was no difference between the TBI
group and the MDL+TBI group, p = .750. In the CA3, there was an effect of treatment,
F(3,181) = 5.09, p = .002 (Figure 3.9.2). The MDL (M = 125.57, SE = 7.30), TBI (M =
127.20, SE = 7.30), and the MDL+TBI (M = 139.91, SE = 7.48) groups all had more cell
death than the control group (M = 100.00, SE = 7.39), p = .015, p =.010, and p < .001,
respectively. There was no difference between the TBI and the MDL+TBI groups, p =
.225. In the DG, there was an effect of treatment, F(3,181) = 9.014, p < .001 (Figure 3.9.3).
The MDL (M = 134.61, SE = 5.81), TBI (M = 137.36, SE = 5.81), and the MDL+TBI (M
= 133.21, SE = 5.95) groups all had more cell death than the control group (M = 100.00,
SE = 5.88), p < .001. There was no difference between the TBI and MDL+TBI conditions,
p = .618.
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3.3.2

Effect of Sex
3.3.2.1 24 Hours
There was no effect of sex at 24 hours in the CA1, F(1,181) = 2.68, p = .103 (Figure

3.7.1), the CA3, F(1,181) = 0.58 (Figure 3.7.2), p = .446, or in the DG, F(1,181) = 1.97, p
= .162 (Figure 3.7.3).
3.3.2.2 48 Hours
There was no effect of sex in the CA1 at 48 hours, F(1,181) = 1.94, p = .165 (Figure
3.8.1) or in the CA3, F(1,181) = 2.91, p = .090 (Figure 3.8.2). There was an effect of sex
in the DG, F(1,181) = 11.28, p = .001 (Figure 3.8.3). Female slices (M = 103.74, SE =
4.68) had less cell death compared to male slices (M = 126.39, SE = 4.86).
3.3.2.3 72 Hours
There was no effect of sex in the CA1, F(1,181) = 1.81, p = .180 (Figure 3.9.1) or
in the CA3, F(1,181) = 1.60, p = .208 (Figure 3.9.2) at 72 hours. There was an effect of
sex in the DG at 72 hours, F(1,181) = 4.74, p = .031 (Figure 3.9.3). Male slices (M =
132.68, SE = 4.23) had more cell death than female slices (M = 119.91, SE = 4.07).
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Figure 3.1.1: Effects of treatment on propidium iodide (PI) uptake in the CA1 region of
hippocampal slices, 24 hours following treatment. There was no effect of EtOH treatment
(five days of 50mM ethanol) compared to slices in the CTRL condition. Both the TBI and
EtOH+TBI groups showed an increase uptake of PI in the CA1 at 24 hours, compared to
the CTRL group, p < .001. There was no effect of sex, p = .661. Error bars represent
standard error.
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Figure 3.1.2: Effects of treatment on propidium iodide (PI) uptake in the CA3 region of
hippocampal slices, 24 hours following treatment. There was no effect of treatment, p =
.427 or an effect of sex, p = .255. Error bars represent standard error.
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Figure 3.1.3: Effects of treatment on propidium iodide (PI) uptake in the DG region of
hippocampal slices, 24 hours following treatment. There was no effect of treatment, p =
.544 or an effect of sex, p = .504. Error bars represent standard error.
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Figure 3.2.1: Effects of treatment on propidium iodide (PI) uptake in the CA1 region of
hippocampal slices, 48 hours following treatment. There was no effect of EtOH treatment
(five days of 50mM ethanol) compared to slices in the CTRL condition. Both the TBI and
EtOH+TBI groups showed an increase uptake of PI in the CA1 at 48 hours, compared to
the CTRL group, p < .001. There was no effect of sex, p = .112.
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Figure 3.2.2: Effects of treatment on propidium iodide (PI) uptake in the CA3 region of
hippocampal slices, 48 hours following treatment. There was no effect of treatment, p =
.22. There was an effect of sex (**), p = .045. At 48 hours, the CA3 region of female
slices took up more PI than the CA3 region of male slices. Error bars represent standard
error.
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Figure 3.2.3: Effects of treatment on propidium iodide (PI) uptake in the DG region of
hippocampal slices, 48 hours following treatment. There was no effect of treatment, p =
.418. There was an effect of sex (**), p = .049. At 48 hours, the DG region of female
slices took up more PI than the DG region of male slices. Error bars represent standard
error.
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Figure 3.3.1: Effects of treatment on propidium iodide (PI) uptake in the CA1 region of
hippocampal slices, 72 hours following treatment. There was no effect of EtOH treatment
(five days of 50mM ethanol) compared to slices in the CTRL condition. Both the TBI and
EtOH+TBI groups showed an increase uptake of PI in the CA1 at 72 hours, compared to
the CTRL group, p < .001. There was no effect of sex, p = .774. Error bars represent
standard error.
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Figure 3.3.2: Effects of treatment on propidium iodide (PI) uptake in the CA3 region of
hippocampal slices, 48 hours following treatment. There was no effect of treatment, p =
.490 or an effect of sex, p = .366.
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Figure 3.3.3: Effects of treatment on propidium iodide (PI) uptake in the DG region of
hippocampal slices, 72 hours following treatment. There was no effect of treatment, p =
.791 or an effect of sex, p = .699. Error bars represent standard error.
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Figure 3.4.1: Effects of treatment on propidium iodide (PI) uptake in the CA1 region of
hippocampal slices, 24 hours following treatment. All treatment conditions resulted in
more uptake of PI compared to the CTRL group. EWD vs. CTRL, p = .003; TBI vs. CTRL,
p < .001; and EWD+TBI vs. CTRL, p < .001. There was an effect of sex, p = .005. At 24
hours, the CA1 region of female slices took up more PI than the CA1 region of male slices.
Error bars represent standard error.
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Figure 3.4.2: Effects of treatment on propidium iodide (PI) uptake in the CA3 region of
hippocampal slices, 24 hours following treatment. All treatment conditions resulted in
more uptake of PI compared to the CTRL group. EWD vs. CTRL, p = .007; TBI vs. CTRL,
p = .006; and EWD+TBI vs. CTRL, p < .001. There was an effect of sex, p = .019. At 24
hours, the CA3 region of female slices took up more PI than the CA1 region of male slices.
Error bars represent standard error.
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Figure 3.4.3: Effects of treatment on propidium iodide (PI) uptake in the DG region of
hippocampal slices, 24 hours following treatment. All treatment conditions resulted in
more uptake of PI compared to the CTRL group. EWD vs. CTRL, p = .016; TBI vs. CTRL,
p = .003; and EWD+TBI vs. CTRL, p = .001. There was no effect of sex, p = .124. Error
bars represent standard error.
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Figure 3.5.1: Effects of treatment on propidium iodide (PI) uptake in the CA1 region of
hippocampal slices, 48 hours following treatment. All treatment conditions resulted in
more uptake of PI compared to the CTRL group. EWD vs. CTRL, p = .002; TBI vs. CTRL,
p < .001; and EWD+TBI vs. CTRL, p < .001. There was an effect of sex, p = .009. At 48
hours, the CA1 region of female slices took up more PI than the CA1 region of male slices.
Error bars represent standard error.
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Figure 3.5.2: Effects of treatment on propidium iodide (PI) uptake in the CA3 region of
hippocampal slices, 48 hours following treatment. All treatment conditions resulted in
more uptake of PI compared to the CTRL group. EWD vs. CTRL, p = .008; TBI vs. CTRL,
p = .004; and EWD+TBI vs. CTRL, p = .001. There was no effect of sex, p = .749. Error
bars represent standard error.
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Figure 3.5.3: Effects of treatment on propidium iodide (PI) uptake in the CA3 region of
hippocampal slices, 48 hours following treatment. There was no effect of treatment, p =
.084 or an effect of sex, p = .674. Error bars represent standard error.
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Figure 3.6.1: Effects of treatment on propidium iodide (PI) uptake in the CA1 region of
hippocampal slices, 72 hours following treatment. There was no effect of EWD treatment
(five days of 50mM ethanol followed by 24 hours of control media) compared to slices in
the CTRL condition. Both the TBI and EWD+TBI groups showed an increase uptake of
PI in the CA1 at 72 hours, compared to the CTRL group, p < .001. There was an increase
in PI uptake in the EWD+TBI condition compared with the TBI group (#), p = .032. There
was no effect of sex, p = .086. Error bars represent standard error.
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Figure 3.6.2: Effects of treatment on propidium iodide (PI) uptake in the CA3 region of
hippocampal slices, 72 hours following treatment. There was no effect of EWD treatment
(five days of 50mM ethanol followed by 24 hours of control media) compared to slices in
the CTRL condition or an effect of TBI treatment compared to the CTRL condition. The
EWD+TBI group showed an increase uptake of PI in the CA3 at 72 hours, compared to the
CTRL group, p = .025. There was an increase in PI uptake in the EWD+TBI condition
compared with the TBI group (#), p = .025. There was no effect of sex, p = .890. Error
bars represent standard error.
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Figure 3.6.3: Effects of treatment on propidium iodide (PI) uptake in the DG region of
hippocampal slices, 72 hours following treatment. There was an increased uptake of PI in
the EWD and EWD+TBI groups compared with the CTRL group, p = .001 and p = .017,
respectively. There was no effect of the TBI treatment compared to the CTRL condition.
The EWD+TBI group showed an increase uptake of PI in the DG at 72 hours, compared
to the CTRL group, p = .025. There was an increase in PI uptake in the EWD+TBI
condition compared with the TBI group (#), p = .009. There was no effect of sex, p = .153.
Error bars represent standard error.
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Figure 3.7.1: Effects of treatment on propidium iodide (PI) uptake in the CA1 region of
hippocampal slices, 24 hours following treatment. There was no effect of MDL treatment
compared to slices in the CTRL condition. Both the TBI and MDL+TBI groups showed
an increase uptake of PI in the CA1 at 24 hours, compared to the CTRL group, p < .001.
There was no effect of sex, p = .103. Error bars represent standard error.
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Figure 3.7.2: Effects of treatment on propidium iodide (PI) uptake in the CA3 region of
hippocampal slices, 24 hours following treatment. There was no effect of MDL treatment
or the MDL+TBI treatment compared to slices in the CTRL condition. The TBI group
showed an increase uptake of PI in the CA3 at 24 hours, compared to the CTRL group, p
= .012. There was no effect of sex, p = .446. Error bars represent standard error.

73

Propidium Iodide Uptake
(% CTRL)

24 Hours in DG
300

Male
Female

200

100

0
CTRL

MDL

TBI

MDL+TBI

Treatment Group

Figure 3.7.3: Effects of treatment on propidium iodide (PI) uptake in the DG region of
hippocampal slices, 24 hours following treatment. There was no effect of treatment or an
effect of sex, p = .052 and p = .162. Error bars represent standard error.
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3.8.1: Effects of treatment on propidium iodide (PI) uptake in the CA1 region of
hippocampal slices, 48 hours following treatment. There was no effect of MDL treatment
compared to slices in the CTRL condition. Both the TBI and MDL+TBI groups showed
an increase uptake of PI in the CA1 at 48 hours, compared to the CTRL group, p < .001.
There was no effect of sex, p = .165. Error bars represent standard error.
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Figure 3.8.2: Effects of treatment on propidium iodide (PI) uptake in the CA3 region of
hippocampal slices, 48 hours following treatment. There was no effect of MDL treatment
or the MDL+TBI treatment compared to slices in the CTRL condition. The TBI group
showed an increase uptake of PI in the CA3 at 48 hours, compared to the CTRL group, p
= .009. There was no effect of sex, p = .090. Error bars represent standard error.
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Figure 3.8.3: Effects of treatment on propidium iodide (PI) uptake in the DG region of
hippocampal slices, 48 hours following treatment. There was no effect of MDL treatment
or the MDL+TBI treatment compared to slices in the CTRL condition. The TBI group
showed an increase uptake of PI in the DG at 48 hours, compared to the CTRL group, p =
.002. There was an effect of sex (**), p = .001. At 48 hours, the DG region of male slices
took up more PI than the DG region of female slices. Error bars represent standard error.
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Figure 3.9.1: Effects of treatment on propidium iodide (PI) uptake in the CA1 region of
hippocampal slices, 72 hours following treatment. There was no effect of MDL treatment
compared to slices in the CTRL condition. Both the TBI and MDL+TBI groups showed
an increase uptake of PI in the CA1 at 48 hours, compared to the CTRL group, p < .001.
There was no effect of sex, p = .180. Error bars represent standard error.
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Figure 3.9.2: Effects of treatment on propidium iodide (PI) uptake in the CA3 region of
hippocampal slices, 72 hours following treatment. All treatment conditions resulted in
more uptake of PI compared to the CTRL group. MDL vs. CTRL, p = .015; TBI vs. CTRL,
p = .010; and MDL+TBI vs. CTRL, p < .001. There was no effect of sex, p = .208. Error
bars represent standard error.

79

Propidium Iodide Uptake
(% CTRL)

72 Hours in DG
300

Male
Female**

200

*

*

MDL

TBI

*

100

0
CTRL

MDL+TBI

Treatment Group

Figure 3.9.3: Effects of treatment on propidium iodide (PI) uptake in the DG region of
hippocampal slices, 72 hours following treatment. All treatment conditions resulted in
more uptake of PI compared to the CTRL group. MDL vs. CTRL, p < .001; TBI vs. CTRL,
p < .001; and MDL+TBI vs. CTRL, p < .001. There was an effect of sex (**), p = .031.
At 72 hours, the DG region of male slices took up more PI than the DG region of female
slices. Error bars represent standard error.
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CHAPTER 4. DISCUSSION
In experiment 1, unsurprisingly, the application of a transection (cut) to the CA1 in
both the TBI alone and the EtOH+TBI resulted in increased propidium iodide (PI) uptake
in the CA1, indicative of increased cell death. This was seen at each time point the slices
were imaged. There was not an effect of the EtOH treatment on PI uptake in the CA1, but
this is consistent with (Reynolds, Berry, Sharrett-Field, and Prendergast, 2015). Also the
effect of the TBI treatment was limited to the area of injury (CA1), with no effect of
treatment in either the CA3 or the DG. While it is not surprising that the most pronounced
effect would be seen at the site of injury, it is unexpected that there was no effect of
treatment seen in either the CA3 or the DG, as animal models of TBI show a tendency of
injuries to spread after the initial insult due to secondary injury processes (Hawryluk and
Manley, 2015). However, a possible explanation for this unexpected finding is that,
although an effort was made to image at different time points to capture the progression of
secondary injury mechanisms, the time points may have been too long after the initial insult
to capture injury expansion. Different secondary injury mechanisms can occur minutes to
days after the initial insult (e.g. Liu, Yin, Zhang, and Qian, 2014; Nakajima et al., 2010),
so future investigations may wish to image more closely following the initial injury, as
image at more frequent intervals. At the 48-hour mark, there was some indication that
female slices had more cell death than male slices, but only in the CA3 and DG. Given
that there was not an effect of treatment in these regions, caution should be used in the
interpretation of this finding. Even in the CA1, where there was an effect of treatment and
both TBI and EtOH+TBI showed an increase in cell death, there was no difference between
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the slices that were intoxicated at the time of injury (EtOH+TBI) and slices in the control
media at the time of injury. This finding adds to the confusing and conflicting previous
results regarding alcohol intoxication at the time of TBIs (Berry et al., 2011; Cunningham
et al., 2002; Dikmen et al., 1993; Gurney et al., 1992; Gururaj, 2004; Joseph et al., 2015;
Lange et al., 2008; Lange et al., 2014; Mathias and Osborn, 2018; Pandit et al., 2014; Raj
et al., 2015; Ruff et al., 1990; Scheene et al., 2016; Shahin and Robertson, 2012; Shandro
et al., 2009; Tien et al., 2006). However, an additional limitation of this model is that the
TBI mechanism used in this study was quite severe and focal in nature, which may have
resulted in a ceiling effect. Efforts should be made to replicate these experiments using
different, and less severe, models of TBI to determine if a potential ceiling effect may have
influenced the findings. Although the values changed between time points, due in part to
the fluorescent marker, in this experiment, overall the same pattern of effects were seen at
24, 48, and 72 hours following injury (aside from the unexpected sex effect in the CA3 and
DG at 48 hours), which may indicate these time points may not be the most beneficial for
capturing the dynamic nature of TBIs, as modeled in this experiment.
In experiment 2, in the CA1, CA3, and DG at 24 hours, all three treatment groups
(EWD, TBI, and EWD+TBI) had more PI uptake (cell death) than the slices in the control
condition. Unlike in experiment 1 where the damage was limited to the area of injury
(CA1), in this experiment, increased cell death is seen in the other regions of the
hippocampus. At 24 hours in the CA1, CA3, and at 48 hours in the CA1, there was an
effect of sex. At these time points in these regions, female slices had more PI uptake n
average compared to male slices. This result was not hypothesized, but was not necessarily
surprising. Clinical data is mixed with some studies finding no difference in TBI outcomes

82

between men and women however, women experiencing worse outcomes following a TBI
than men, and women experiencing better outcomes than men (for review, see Gupte,
Brooks, Vukas, Pierce, and Harris, 2019). One concern in TBI research is that female
participants are not always included or included in sufficient numbers (Gupte et al., 2019),
which may be in part due to the increased likelihood of men obtaining TBIs compared to
women (Faul et al., 2010). Interestingly, at the 72-hour time point, there is some indication
that slices in the EWD+TBI group have more cell death than slices in the TBI alone group.
In the CA1, while both the TBI and EWD+TBI have more cell death than the CTRL group,
the EWD+TBI group has significantly more cell death than the TBI alone group. In the
CA3, the only treatment group that has more PI uptake than the CTRL group is the
EWD+TBI group, and it has more cell death than the TBI alone group, which was not
different from CTRL slices. In the DG, only the EWD and EWD+TBI groups had more
cell death than the CTRL group-the TBI alone group did not. Additionally, the EWD+TBI
group had more cell death than the TBI alone group. This finding was anticipated, as it
was hypothesized that EWD would sensitize NMDA receptors, exacerbating the
excitotoxicity seen following the initial injury.
In experiment 3, in the CA1 at 24, 48, and 72 hours, both the TBI and MDL+TBI
groups had more cell death than the CTRL group. Interestingly, in the CA3 at 24 and 48
hours as well as the DG at 48 hours there was more cell death in the TBI group compared
to the CTRL group, but the MDL+TBI group did not. While there was no statistical
difference between the TBI and MDL+TBI groups, this difference at the non-injured areas
should be investigated further to see if this finding was an anomaly, or if there may be a
true therapeutic effect of MDL in these regions. Also, at 72 hours in the CA3 and DG, in
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addition to both the TBI and MDL+TBI groups having more cell death than the CTRL
group, the MDL group has also become toxic and had more cell death than the CTRL
group. Given the nonspecific mechanism MDL is targeting, it is possible that it can cause
toxicity in its own right.
The purpose of these experiments was to characterize a model of TBI in OHSC and
to study the effect of alcohol intoxication and withdrawal prior to TBI on cell death as well
as to investigate a potential therapeutic to elucidate a secondary mechanism of injury in a
controlled manner to further disease mechanisms prior to experiments in live animals.
There were several limitations to these experiments. For one, the mechanism of injury
used is not a common one in clinical TBI populations and was potentially too severe to
determine the effects of alcohol intoxication and withdrawal prior to TBI. Another
limitation was that imaging time points were chosen to try and capture the progressive
nature of TBIs, but may have been too late following the injury. Another limitation was
that the drug administered is not specific and can cause dysfunction in healthy cells.
Additionally, given that different litters of pups can give very different results, it is
important future studies use multiple litters to ensure the effects are consistent. Another
limitation of this study was that only one mechanism of secondary injury was looked atexcitotoxicity. By also looking at another secondary injury mechanism, such as various
inflammatory markers, a more complete picture can be made. In that same vein, by using
a fluorescent marker such at NeuN that will specifically show live neurons, a more
complete picture can be formed, instead of just looking at PI uptake, which will stain all
types of dead cells.
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